var title_f10_30_10720="Computed tomography scan of acute pyelonephritis";
var content_f10_30_10720=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F69393&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F69393&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Computed tomography scan of acute pyelonephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 241px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Contrast-enhanced CT scan in a patient with acute pyelonephritis showing a large, hypodense region in the right kidney. There is no discrete abscess formation in this setting.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Alain Meyrier, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10720=[""].join("\n");
var outline_f10_30_10720=null;
var title_f10_30_10721="Diphtheria and tetanus toxoid: Patient drug information";
var content_f10_30_10721=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Diphtheria and tetanus toxoid: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10519?source=see_link\">",
"     see \"Diphtheria and tetanus toxoid: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/31/30198?source=see_link\">",
"     see \"Diphtheria and tetanus toxoid: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F161214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Decavac&reg; [DSC];",
"     </li>",
"     <li>",
"      Tenivac&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2934425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Td Adsorbed",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt adi-os drugH1Div\" id=\"F10024219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     CDC Information",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Vaccine Information Statements (VIS) are made by the staff of the Centers for Disease Control and Prevention (CDC). Each VIS gives information to properly inform the adult receiving the vaccine or, in the case of a minor, the child's parent or legal representative about the risks and benefits of each vaccine. Before a doctor vaccinates a child or an adult, the provider is required by the National Childhood Vaccine Injury Act to give a copy of the VIS. You can also get foreign language versions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2706007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <a href=\"file://www.immunize.org/vis/vis_td-tdap.asp\" target=\"_blank\">",
"        Vaccine Information Statements (VIS)",
"       </a>",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12205 Version 27.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-200.215.4.194-6EBEB1F6CE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10721=[""].join("\n");
var outline_f10_30_10721=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161214\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2934425\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024219\">",
"      CDC Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10519?source=related_link\">",
"      Diphtheria and tetanus toxoid: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/31/30198?source=related_link\">",
"      Diphtheria and tetanus toxoid: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_30_10722="Patient information: Optic neuritis (The Basics)";
var content_f10_30_10722=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"13\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83437\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/27/29105\">",
"         Parts of the eye",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?39/31/40447\">",
"         Patient information: Multiple sclerosis in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?43/22/44389\">",
"         Patient information: Vasculitis (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Optic neuritis (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/optic-neuritis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H100747755\">",
"      <span class=\"h1\">",
"       What is optic neuritis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Optic neuritis is a condition that causes vision problems, eye pain, and other symptoms. It happens when the nerve that goes from the eye to the brain gets inflamed (",
"      <a class=\"graphic graphic_figure graphicRef70420 \" href=\"UTD.htm?28/27/29105\">",
"       figure 1",
"      </a>",
"      ). This nerve is called the &ldquo;optic nerve.&rdquo;",
"     </p>",
"     <p>",
"      Optic neuritis is common in people who have a disease called &ldquo;multiple sclerosis&rdquo; (called &ldquo;MS,&rdquo; for short). It can also happen in people who have no other health conditions.",
"     </p>",
"     <p>",
"      Optic neuritis sometimes happens to people who have conditions other than MS. But this is not common. The conditions include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Infections &ndash; Children are more likely to get optic neuritis after an infection, such as chickenpox or the flu.",
"       </li>",
"       <li>",
"        Diseases that affect the body&rsquo;s infection-fighting system (called the &ldquo;immune system&rdquo;) - These include lupus and sarcoid.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H100747770\">",
"      <span class=\"h1\">",
"       What are the symptoms of optic neuritis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Optic neuritis usually happens in 1 eye at a time. But it sometimes happens in both eyes. The main symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Vision loss &ndash; A person with optic neuritis usually has trouble seeing clearly from 1 or both eyes. Vision usually gets worse for several hours or days. Most people do not lose all their vision. Vision usually starts to get better in a few weeks.",
"       </li>",
"       <li>",
"        Eye pain &ndash; The eyes might hurt more when they move. Pain usually starts when vision starts to get worse. As vision gets better, the pain goes away.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Less common symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Seeing flashes or flickers of light",
"       </li>",
"       <li>",
"        Having trouble seeing colors &ndash; You might think that bright colors look dark",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H100747785\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse right away if you start to lose your vision.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H100747800\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Doctors will do tests to see if optic neuritis is the cause of your symptoms. They will also check for signs of MS. This is because optic neuritis can be the first symptom of MS.",
"     </p>",
"     <p>",
"      You will have the following tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Dilated eye exam &mdash; During this exam, the eye doctor gives you eye drops to make your pupils open up. (When your pupils are open, it is easier for the doctor to see the different parts of the inside of your eye.) After the drops open your pupils, the doctor looks at the back of your eye, where the optic nerve is. He or she looks for signs of optic neuritis.",
"       </li>",
"       <li>",
"        MRI of the brain &ndash; This is an imaging test that creates pictures of the brain. It can show changes to the optic nerve and brain. It can help doctors find MS or another condition that is causing the optic neuritis.",
"       </li>",
"       <li>",
"        Blood tests &ndash; Doctors do these to look for signs of MS or conditions that sometimes happen with MS.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people also have a test called a &ldquo;lumbar puncture.&rdquo; Another name for this test is a &ldquo;spinal tap.&rdquo; In this procedure, a doctor puts a thin needle into your lower back and takes out a small amount of spinal fluid. Spinal fluid is the fluid around your brain and spinal cord. Lab tests of the fluid can tell the doctor more about what is causing the optic neuritis. Most people do not need this test, but some do. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H100747815\">",
"      <span class=\"h1\">",
"       How is optic neuritis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Optic neuritis usually gets better without treatment. This can take a few weeks or many months.",
"     </p>",
"     <p>",
"      Doctors can treat severe optic neuritis with steroid medicines given through a thin tube called an &ldquo;IV.&rdquo; The tube goes into a vein. The medicines help the optic neuritis go away faster.",
"     </p>",
"     <p>",
"      If you have optic neuritis and your MRI shows you are at high risk of getting MS, your doctor might give you medicines. These medicines can slow down the MS or keep it from happening. They include",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?38/5/38997?source=see_link\">",
"       interferon beta-1a",
"      </a>",
"      (sample brand names: Avonex,&reg; Rebif&reg;) or interferon beta 1b (sample brand names: Betaseron&reg;, Extavia&reg;).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H100747830\">",
"      <span class=\"h1\">",
"       Will my vision get better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most patients start to see better in a few weeks. After 1 year, most people have vision that is almost as good as before the optic neuritis. But some people have lifelong vision loss or even blindness.",
"     </p>",
"     <p>",
"      About 1 of every 3 people who get optic neuritis gets it again later.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H100747845\">",
"      <span class=\"h1\">",
"       Will I get MS?",
"      </span>",
"      &nbsp;&mdash;&nbsp;About half the people who get optic neuritis get MS in the next 15 years. If the results of your MRI are normal, you have less chance of getting MS. If the MRI shows changes to the optic nerve and brain, you have a higher chance of MS. People with more changes have a higher risk than people with just a few.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H100747860\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/31/40447?source=see_link\">",
"       Patient information: Multiple sclerosis in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/22/44389?source=see_link\">",
"       Patient information: Vasculitis (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?10/30/10722?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83437 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-61.234.146.186-C2D6B77659-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10722=[""].join("\n");
var outline_f10_30_10722=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H100747755\">",
"      What is optic neuritis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H100747770\">",
"      What are the symptoms of optic neuritis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H100747785\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H100747800\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H100747815\">",
"      How is optic neuritis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H100747830\">",
"      Will my vision get better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H100747845\">",
"      Will I get MS?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H100747860\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83437\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/27/29105\">",
"      Parts of the eye",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/31/40447?source=related_link\">",
"      Patient information: Multiple sclerosis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/22/44389?source=related_link\">",
"      Patient information: Vasculitis (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_30_10723="Biomechanic loading models";
var content_f10_30_10723=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F71590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F71590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 477px\">",
"   <div class=\"ttl\">",
"    Types of stress on bone and resulting fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 457px; height: 488px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10723=[""].join("\n");
var outline_f10_30_10723=null;
var title_f10_30_10724="Travoprost: Patient drug information";
var content_f10_30_10724=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Travoprost: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/52/22339?source=see_link\">",
"     see \"Travoprost: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F230214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Travatan Z&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F230215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Travatan Z&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691860",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat glaucoma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower high eye pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to travoprost or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016195\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697236",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an eye infection, eye surgery, or eye injury, start a new bottle of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698504",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your eye pressure checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blurred eyesight. Use care when driving or doing other tasks that call for clear eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye color may change with use. This drug may raise the brown pigment. Dark eyelashes and skin around the eye may also happen. These changes may be long-lasting.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016200\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11114 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-A161942C46-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10724=[""].join("\n");
var outline_f10_30_10724=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230214\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230215\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016191\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016190\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016195\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016196\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016198\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016193\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016194\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016199\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016200\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/52/22339?source=related_link\">",
"      Travoprost: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_30_10725="Amsacrine: Patient drug information";
var content_f10_30_10725=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Amsacrine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/5/37973?source=see_link\">",
"     see \"Amsacrine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2935690\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      AMSA PD",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10031445\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700794",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause tissue damage if the drug leaks from the vein. Tell your nurse if you have any redness, burning, pain, swelling, or leaking of fluid where the drug is going into your body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031447\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691928",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat leukemia.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031446\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701519",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to amsacrine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703822",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bone marrow disease from chemo or radiation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031451\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697022",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy. Use birth control that you can trust.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697958",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in color of urine to orange or red.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698217",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low potassium levels like muscle pain or weakness, muscle cramps, or a heartbeat that does not feel normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698126",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the heart may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031454\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low potassium.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031449\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031455\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11291 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-210.101.131.231-3DC0084E0B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10725=[""].join("\n");
var outline_f10_30_10725=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2935690\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031445\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031447\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031446\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031451\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031452\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031454\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031449\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031450\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031455\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031456\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?37/5/37973?source=related_link\">",
"      Amsacrine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_30_10726="Donepezil: Drug information";
var content_f10_30_10726=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Donepezil: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?40/11/41140?source=see_link\">",
"    see \"Donepezil: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F162576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aricept&reg;;",
"     </li>",
"     <li>",
"      Aricept&reg; ODT",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F162577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Aricept&reg;;",
"     </li>",
"     <li>",
"      Aricept&reg; RDT",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F162609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Acetylcholinesterase Inhibitor (Central)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F162581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Alzheimer's dementia:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mild-to-moderate: Initial: 5 mg once daily; may increase to 10 mg once daily after 4-6 weeks; effective dosage range in clinical studies: 5-10 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Moderate-to-severe: Initial: 5 mg once daily; may increase to 10 mg once daily after 4-6 weeks; may increase further to 23 mg once daily after &ge;3 months; effective dosage range in clinical studies: 10-23 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F162582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"     <b>",
"      Note:",
"     </b>",
"     The Canadian labeling recommends a maximum dose of 5 mg once daily in elderly women of low body weight.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15804856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adjustment provided in manufacturer&rsquo;s labeling. Limited data suggest severe renal impairment does not adversely affect donepezil clearance.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15804857\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F162555\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 5 mg, 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aricept&reg;: 5 mg, 10 mg, 23 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, orally disintegrating, oral, as hydrochloride: 5 mg, 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aricept&reg; ODT: 5 mg, 10 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F162541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F759356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer at bedtime without regard to food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aricept&reg; 5 mg or 10 mg tablet: Swallow whole with water.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aricept&reg; 23 mg tablet: Swallow whole with water; do",
"     <b>",
"      NOT",
"     </b>",
"     crush or chew due to an increased rate of absorption. The 23 mg strength is provided in a unique film-coated formulation different from the 5 mg or 10 mg tablet strengths, which results in an altered pharmacokinetic profile.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aricept&reg; ODT: Allow tablet to dissolve completely on tongue and follow with water.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F162557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of mild, moderate, or severe dementia of the Alzheimer's type",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F162605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Behavioral syndromes in dementia; mild-to-moderate dementia associated with Parkinson's disease; Lewy body dementia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F162616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Aricept&reg; may be confused with AcipHex&reg;, Ascriptin&reg;, and Azilect&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F162607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Insomnia (2% to 14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (3% to 19%; dose related), diarrhea (5% to 15%; dose related)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Accident (7% to 13%), infection (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypertension (3%), chest pain (2%),  hemorrhage (2%), syncope (2%), hypotension, atrial fibrillation, bradycardia, ECG abnormal, edema, heart failure, hot flashes, peripheral edema, vasodilation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (3% to 10%), pain (3% to 9%), fatigue (1% to 8%), dizziness (2% to 8%), abnormal dreams (3%), hostility (3%), nervousness (1% to 3%), hallucinations (3%), depression (2% to 3%), confusion (2%), emotional lability (2%), personality disorder (2%), fever (2%), somnolence (2%), abnormal crying, aggression, agitation, anxiety, aphasia, delusions, irritability, restlessness, seizure, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Bruising (4% to 5%), eczema (3%), pruritus, rash, skin ulcer, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dehydration (1% to 2%), hyperlipemia (2%), libido increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Anorexia (2% to 8%), vomiting (3% to 9%; dose related), weight loss (3% to 5%; dose related), abdominal pain, bloating, constipation, dyspepsia, epigastric pain, fecal incontinence, gastroenteritis, GI bleeding, toothache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary frequency (2%), urinary incontinence (1% to 3%), cystitis, hematuria, glycosuria, nocturia, UTI",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Contusion (&le;2%), anemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Muscle cramps (3% to 8%), back pain (3%), CPK increased (3%), arthritis (1% to 2%), ataxia, bone fracture, gait abnormal, lactate dehydrogenase increased, paresthesia, tremor, weakness (1% to 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Blurred vision, cataract, eye irritation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Bronchitis, cough increased, dyspnea, pharyngitis, pneumonia, sore throat",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, fungal infection, flu symptoms, wandering",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Angina, cardiomegaly, cerebrovascular accident, cholecystitis, conjunctival hemorrhage, deep vein thrombosis, diabetes mellitus, diverticulitis, gastrointestinal ulcer, glaucoma, heart block, heart failure, hemolytic anemia, hepatitis, hyperglycemia, hypertonia, hypokalemia, hypokinesia, hyponatremia, hypoxia, intracranial hemorrhage, jaundice, LFTs increased, MI, neuroleptic malignant syndrome, pancreatitis, pleurisy, pulmonary collapse, pulmonary congestion, pyelonephritis, renal failure, retinal hemorrhage, SVT, thrombocythemia, thrombocytopenia, tongue edema, transient ischemic attack",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F162560\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to donepezil, piperidine derivatives, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F162545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anorexia/weight loss: May cause anorexia and/or weight loss (dose-related).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; GI effects: May cause dose-related diarrhea, nausea, and/or vomiting; usually resolves in 1-3 weeks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vagotonic effects: Cholinesterase inhibitors may have vagotonic effects which may cause bradycardia and/or heart block with or without a history of cardiac disease; syncopal episodes have been associated with donepezil.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiac conduction abnormalities: Use with caution in patients with sick-sinus syndrome, bradycardia, or conduction abnormalities. Alzheimer's treatment guidelines consider bradycardia to be a relative contraindication for use of centrally-active cholinesterase inhibitors.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Peptic ulcer disease: Use with caution in patients at risk of ulcer disease (eg, previous history or NSAID use); cholinesterase inhibitors may increase gastric acid secretion. Monitor for symptoms of bleeding.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory disease: Use with caution in patients with COPD and/or asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients with a history of seizure disorder; cholinomimetics may potentially cause generalized seizures, although seizure activity may also result from Alzheimer&rsquo;s disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Urinary tract obstruction: Use with caution in patients with bladder outlet obstruction or prostatic hyperplasia; cholinomimetics may cause or worsen outflow obstructions, including possible exacerbation of BPH symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Low-weight patients: Patients weighing &lt;55 kg may experience more nausea, vomiting, and weight loss than patients &ge;55 kg.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Depolarizing neuromuscular-blocking agents: May exaggerate neuromuscular blockade effects of depolarizing neuromuscular-blocking agents (eg, succinylcholine).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F162602\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2D6 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F162550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics: Acetylcholinesterase Inhibitors (Central) may enhance the neurotoxic (central) effect of Antipsychotics. Severe extrapyramidal symptoms have occurred in some patients.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Acetylcholinesterase Inhibitors may enhance the bradycardic effect of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholinergic Agonists: Acetylcholinesterase Inhibitors may enhance the adverse/toxic effect of Cholinergic Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the adverse/toxic effect of Acetylcholinesterase Inhibitors. Increased muscular weakness may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dipyridamole: May diminish the therapeutic effect of Acetylcholinesterase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents (Nondepolarizing): Acetylcholinesterase Inhibitors may diminish the neuromuscular-blocking effect of Neuromuscular-Blocking Agents (Nondepolarizing).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: Acetylcholinesterase Inhibitors may increase the serum concentration of Succinylcholine.  Management: Consider alternatives to this combination due to a risk of prolonged neuromuscular blockade.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F162573\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Herb/Nutraceutical: St John's wort may decrease donepezil levels. Ginkgo biloba may increase adverse effects/toxicity of acetylcholinesterase inhibitors.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F162551\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F162564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies. There are no adequate and well-controlled studies in pregnant women.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F162584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F759355\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May take with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F162563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, orally-disintegrating",
"     </b>",
"     (Aricept ODT Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (30): $392.39",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $392.39",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, orally-disintegrating",
"     </b>",
"     (Donepezil HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (30): $233.62",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $233.62",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Aricept Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (90): $1177.28",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $392.39",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     23 mg (30): $350.52",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Donepezil HCl Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (30): $259.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg (30): $259.50",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F162553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Behavior, mood, bowel function, cognitive function, general function (eg, activities of daily living)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F162565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aldomer (ID);",
"     </li>",
"     <li>",
"      Aloxtra (ID);",
"     </li>",
"     <li>",
"      Alzaimax (AR);",
"     </li>",
"     <li>",
"      Alzim (ID);",
"     </li>",
"     <li>",
"      Alzit (PA);",
"     </li>",
"     <li>",
"      Arcdone (TW);",
"     </li>",
"     <li>",
"      Aricept (AE, AT, AU, BD, BE, BF, BG, BH, BJ, CH, CI, CL, CY, CZ, DE, DK, EE, EG, ES, ET, FI, FR, GB, GH, GM, GN, GR, HK, HN, HU, ID, IE, IL, IQ, IR, IT, JO, JP, KE, KP, KW, LB, LR, LY, MA, ML, MR, MU, MW, MY, NE, NG, NO, NZ, OM, PH, PK, PL, PT, QA, RU, SA, SC, SD, SE, SG, SL, SN, SY, TN, TR, TW, TZ, UG, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Aricept Evess (HK, ID, MY, PH, SG, TH);",
"     </li>",
"     <li>",
"      Aricept Evis (KP);",
"     </li>",
"     <li>",
"      Aricept-D (NZ);",
"     </li>",
"     <li>",
"      Aripe (KP);",
"     </li>",
"     <li>",
"      Asenta (IL);",
"     </li>",
"     <li>",
"      Carencil (PE);",
"     </li>",
"     <li>",
"      Concorda (NZ);",
"     </li>",
"     <li>",
"      Dazolin (CO);",
"     </li>",
"     <li>",
"      Donaz (IN);",
"     </li>",
"     <li>",
"      Done-5 (PH);",
"     </li>",
"     <li>",
"      Donecil (PE);",
"     </li>",
"     <li>",
"      Donef (KP);",
"     </li>",
"     <li>",
"      Donepet (KP);",
"     </li>",
"     <li>",
"      Donezel (PH);",
"     </li>",
"     <li>",
"      Donezil (KP, MY);",
"     </li>",
"     <li>",
"      Dozil (ID);",
"     </li>",
"     <li>",
"      Epalon (TW);",
"     </li>",
"     <li>",
"      Eranz (AR, BR, CN, CO, CR, EC, GT, MX, NI, SV, VE);",
"     </li>",
"     <li>",
"      Fordesia (ID);",
"     </li>",
"     <li>",
"      Memorit (IL);",
"     </li>",
"     <li>",
"      Miracet (KP);",
"     </li>",
"     <li>",
"      Nepes (TW);",
"     </li>",
"     <li>",
"      Neurocept (KP);",
"     </li>",
"     <li>",
"      Neutoin (KP);",
"     </li>",
"     <li>",
"      Nomi-Nox (TW);",
"     </li>",
"     <li>",
"      Piridon (UY);",
"     </li>",
"     <li>",
"      Remecin (TW);",
"     </li>",
"     <li>",
"      Rewise (TW);",
"     </li>",
"     <li>",
"      Silvercept (KP);",
"     </li>",
"     <li>",
"      Tonizep 5 (TH);",
"     </li>",
"     <li>",
"      Torpezil (PH);",
"     </li>",
"     <li>",
"      Vastia (KP);",
"     </li>",
"     <li>",
"      Vencel (PY)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F162544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Alzheimer's disease is characterized by cholinergic deficiency in the cortex and basal forebrain, which contributes to cognitive deficits. Donepezil reversibly and noncompetitively inhibits centrally-active acetylcholinesterase, the enzyme responsible for hydrolysis of acetylcholine. This appears to result in increased concentrations of acetylcholine available for synaptic transmission in the central nervous system.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F162559\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      dss",
"     </sub>",
"     : 12-16 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 96%, primarily to albumin (75%) and &alpha;",
"     <sub>",
"      1",
"     </sub>",
"     -acid glycoprotein (21%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively to four major metabolites (two are active) via CYP2D6 and 3A4; undergoes glucuronidation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 100%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 70 hours; time to steady-state: 15 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: Tablet, 10 mg: 3 hours; Tablet, 23 mg: ~8 hours;",
"     <b>",
"      Note:",
"     </b>",
"     Peak plasma concentrations almost twofold higher for the 23 mg tablet compared to the 10 mg tablet",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine 57% (17% as unchanged drug); feces 15%",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Cubo E, Fernandez Ja&eacute;n A, Moreno C, et al, &ldquo;Donepezil Use in Children and Adolescents With Tics and Attention-Deficit/Hyperactivity Disorder: An 18-Week, Single-Center, Dose-Escalating, Prospective, Open-Label Study,&rdquo;",
"      <i>",
"       Clin Ther",
"      </i>",
"      , 2008, 30(1):182-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/30/10726/abstract-text/18343255/pubmed\" id=\"18343255\" target=\"_blank\">",
"        18343255",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Doyle RL, Frazier J, Spencer TJ, et al, &ldquo;Donepezil in the Treatment of ADHD-Like Symptoms in Youths With Pervasive Developmental Disorder: A Case Series,&rdquo;",
"      <i>",
"       J Atten Disord",
"      </i>",
"      , 2006, 9(3):543-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/30/10726/abstract-text/16481671/pubmed\" id=\"16481671\" target=\"_blank\">",
"        16481671",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hardan AY and Handen BL, &ldquo;A Retrospective Open Trial of Adjunctive Donepezil in Children and Adolescents With Autistic Disorder,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 2002, 12(3):237-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/30/10726/abstract-text/12427297/pubmed\" id=\"12427297\" target=\"_blank\">",
"        12427297",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hoopes SP, &ldquo;Donepezil for Tourette's Disorder and ADHD,&rdquo;",
"      <i>",
"       J Clin Psychopharmacol",
"      </i>",
"      , 1999, 19(4):381-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/30/10726/abstract-text/10440471/pubmed\" id=\"10440471\" target=\"_blank\">",
"        10440471",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hort J, O'Brien JT, Gainotti G, et al, &ldquo;EFNS Guidelines for the Diagnosis and Management of Alzheimer&rsquo;s Disease,&rdquo;",
"      <i>",
"       Eur J Neurol",
"      </i>",
"      ,  2010, 17(10):1236-48.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/30/10726/abstract-text/20831773/pubmed\" id=\"20831773\" target=\"_blank\">",
"        20831773",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rabins PV, Blacker D, Rovner BW, et al, &ldquo;American Psychiatric Association Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Second Edition,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2007, 164(12 Suppl):5-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/30/10726/abstract-text/18340692/pubmed\" id=\"18340692\" target=\"_blank\">",
"        18340692",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rogers SL and Friedhoff LT, &ldquo;The Efficacy and Safety of Donepezil in Patients With Alzheimer's Disease: Results of a U.S. Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial,&rdquo;",
"      <i>",
"       Dementia",
"      </i>",
"      , 1996, 7(6):293-303.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/30/10726/abstract-text/8915035/pubmed\" id=\"8915035\" target=\"_blank\">",
"        8915035",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wilens TE, Biederman J, Wong J, et al, &ldquo;Adjunctive Donepezil in Attention Deficit Hyperactivity Disorder Youth: Case Series,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 2000, 10(3):217-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/30/10726/abstract-text/11052411/pubmed\" id=\"11052411\" target=\"_blank\">",
"        11052411",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wilens TE, Waxmonsky J, Scott M, et al, &ldquo;An Open Trial of Adjunctive Donepezil in Attention-Deficit/Hyperactivity Disorder,&rdquo;",
"      <i>",
"       J Child Adolesc Psychopharmacol",
"      </i>",
"      , 2005, 15(6):947-55.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/30/10726/abstract-text/16379515/pubmed\" id=\"16379515\" target=\"_blank\">",
"        16379515",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9383 Version 42.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-6BEDC4A8C2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10726=[""].join("\n");
var outline_f10_30_10726=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162576\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162577\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162609\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162581\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162582\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15804856\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15804857\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162555\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162541\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F759356\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162557\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162605\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162616\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162607\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162560\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162545\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162602\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162550\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162573\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162551\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162564\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162584\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F759355\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162563\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162553\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162565\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162544\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F162559\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9383\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9383|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?40/11/41140?source=related_link\">",
"      Donepezil: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_30_10727="Platelet dysfunction in uremia";
var content_f10_30_10727=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Platelet dysfunction in uremia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10727/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10727/contributors\">",
"     Jeffrey S Berns, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10727/contributors\">",
"     Steven Coutre, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10727/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10727/contributors\">",
"     Thomas A Golper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10727/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10727/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/30/10727/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The association between renal dysfunction and bleeding was recognized more than 200 years ago [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/1\">",
"     1",
"    </a>",
"    ]. However, there remains an incomplete understanding of the underlying pathophysiology. Impaired platelet function is one of the main determinants of uremic bleeding. This impairment is multifactorial and includes defects intrinsic to the platelet as well as abnormal platelet-endothelial interaction. Uremic toxins and anemia also play a role.",
"   </p>",
"   <p>",
"    This topic reviews platelet dysfunction in uremia. Platelet dysfunction in the general population is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=see_link\">",
"     \"Congenital and acquired disorders of platelet function\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL AND LABORATORY MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical bleeding in uremia may involve the skin resulting in easy bruising, or the oral and nasal mucosa, gingiva, gastrointestinal and urinary tracts, and respiratory system. Excessive bleeding may also occur in response to injury or invasive procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Uremic patients may display increased bleeding sensitivity to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , as there is a transient, cyclooxygenase-independent, prolongation of the bleeding time following the use of aspirin in uremic patients that is greater than that seen in normal subjects taking aspirin [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although an association between bleeding time prolongation and uremia has long been suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/6\">",
"     6",
"    </a>",
"    ], there are no good studies that unequivocally demonstrate an increased risk of either spontaneous bleeding or bleeding with a procedure that is associated with a prolonged bleeding time among patients with chronic kidney disease (CKD).",
"   </p>",
"   <p>",
"    In addition, the degree of azotemia (elevation of the BUN or creatinine) does not correlate with bleeding risk. Despite this, patients undergoing percutaneous renal biopsy and other invasive procedures have in the past been screened for bleeding risk by measuring the bleeding time even though the accuracy, reproducibility, and clinical utility of this test is not clear. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/11/21690?source=see_link&amp;anchor=H9#H9\">",
"     \"Indications for and complications of renal biopsy\", section on 'Prebiopsy evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Generally, levels of circulating coagulation factors are normal (or clotting factors elevated) and there is no prolongation of the prothrombin or partial thromboplastin times unless there is a coexisting coagulopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/7\">",
"     7",
"    </a>",
"    ]. Some patients may have a mild thrombocytopenia but it is rarely severe enough to cause bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other tests of platelet function including aggregation in response to ADP and epinephrine, in vitro closure time, and others are often abnormal in uremic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. There are also abnormalities in protein expression in dysfunctional uremic platelets [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/13\">",
"     13",
"    </a>",
"    ]. These tests are not used clinically to assess bleeding tendency among uremic patients however.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7703983\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of uremic bleeding is multifactorial and includes defects intrinsic to the platelet as well as abnormal platelet-endothelial interaction [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The most important factor is platelet dysfunction. Platelet dysfunction is due to both decreased platelet aggregation and impaired platelet adhesiveness. The impairment in platelet adhesiveness may result at least in part from intrinsic dysfunction of glycoprotein",
"    <span class=\"nowrap\">",
"     IIb/IIIa,",
"    </span>",
"    a platelet membrane glycoprotein that normally plays a major role in both platelet aggregation and adhesion by its interaction with fibrinogen and von Willebrand factor [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/16-18\">",
"     16-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other contributing factors that are intrinsic to platelets include abnormal expression of platelet glycoproteins, altered release of ADP and serotonin from platelet alpha-granules, faulty arachidonic acid and depressed prostaglandin metabolism, decreased platelet thromboxane A2 generation, and abnormal platelet cytoskeletal assembly. Contributing factors that are extrinsic to platelets include the action of uremic toxins, anemia, increased nitric oxide (NO) production, von Willebrand factor abnormalities, decreased platelet production, and abnormal interactions between the platelet and the endothelium of the vessel wall.",
"   </p>",
"   <p>",
"    The best characterized of these factors (uremic toxins, anemia, and NO production) are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Uremic toxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of circulating toxins is suggested by the often beneficial effect of acute dialysis on platelet dysfunction, although the abnormal bleeding time is rarely normalized [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/19\">",
"     19",
"    </a>",
"    ]. The observation that uremic platelets mixed with normal plasma function normally has suggested a plasma factor as the culprit. Consistent with this postulate is the observation that mixing uremic plasma with normal platelets impairs platelet function.",
"   </p>",
"   <p>",
"    Urea is not the major platelet toxin and there is no predictable correlation between the BUN and the bleeding time in patients with renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/6\">",
"     6",
"    </a>",
"    ]. The lack of effect of urea on uremic platelet dysfunction is supported by several observations. As an example, the adverse effect of uremic plasma on platelet function cannot be replicated by adding urea, guanidinoacetic acid, or creatinine to the plasma [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/9\">",
"     9",
"    </a>",
"    ]. Additionally, a report describing three family members with familial azotemia, a rare autosomal dominant condition characterized by high plasma urea levels, demonstrated normal in vitro platelet function [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Guanidinosuccinic acid and methylguanidine have been suggested as potential contributors to uremic platelet dysfunction. High levels of guanidinosuccinic acid and methylguanidine have resulted in abnormal platelet function [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/9\">",
"     9",
"    </a>",
"    ], likely through stimulation of NO production [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Nitric oxide'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia is a common finding among patients with chronic kidney disease and is due primarily to decreased renal erythropoietin production. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients\"",
"    </a>",
"    .) Correction of anemia with blood transfusions or erythropoietic stimulating agents (ESAs) often improves platelet function. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Correction of anemia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    It has been proposed that rheologic factors play an important role in the overall relationship between anemia and platelet function. At a hematocrit above 30 percent, the red cells primarily occupy the center of the vessel, while the platelets are in a skimming layer at the endothelial surface. This close proximity allows the platelets to adhere to the endothelium and then form a platelet plug when there is endothelial injury. With anemia, on the other hand, the platelets are more dispersed, thereby impairing adherence to the endothelium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Nitric oxide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nitric oxide (NO; endothelium-derived relaxing factor) is an inhibitor of platelet aggregation that is produced by endothelial cells and platelets. Studies in uremic patients have shown that platelet NO synthesis is increased and that uremic plasma stimulates NO production by cultured endothelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/22\">",
"     22",
"    </a>",
"    ]. The increase in NO synthesis may be due to elevated levels of guanidinosuccinic acid, a uremic toxin that may be a precursor for nitric oxide in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These findings may be clinically important, since the administration of an NO synthesis inhibitor normalizes the bleeding time in uremic rats [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/23\">",
"     23",
"    </a>",
"    ]. The beneficial effect of estrogens on platelet function in uremic patients may be due, in part, to a reduction of NO synthesis. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Estrogen'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;No specific therapy is required in patients without bleeding even in the setting of severe azotemia. However, correction of platelet dysfunction is desirable in patients who are actively bleeding or who are about to undergo a surgical procedure (eg, renal biopsy). As with any patient, it is important to identify any sources of bleeding and treat those if possible. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/31/20986?source=see_link&amp;anchor=H9#H9\">",
"     \"Gastrointestinal disease in dialysis patients\", section on 'Upper gastrointestinal bleeding'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8410?source=see_link&amp;anchor=H26#H26\">",
"     \"Angiodysplasia of the gastrointestinal tract\", section on 'Endoscopic treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A number of different modalities to improve platelet function and reduce bleeding can be used in this setting, which vary in their onset and duration of action.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7704015\">",
"    <span class=\"h2\">",
"     Dialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Either hemodialysis or peritoneal dialysis can partially correct the bleeding time in approximately two-thirds of uremic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. In bleeding patients, either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    -free hemodialysis or peritoneal dialysis (which does not require heparin administration) may be preferable in patients with active bleeding. If hemodialysis is used, anticoagulation should be avoided, with alternative therapies used if necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/14/38120?source=see_link\">",
"     \"Hemodialysis anticoagulation\"",
"    </a>",
"    .) The comparative effectiveness of peritoneal dialysis compared to hemodialysis in improving uremic bleeding has not been studied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7704093\">",
"    <span class=\"h2\">",
"     Desmopressin (dDAVP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The simplest, most rapidly acting, and probably least toxic acute treatment for platelet dysfunction in the uremic patient is the administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"     desmopressin",
"    </a>",
"    (dDAVP), an analog of antidiuretic hormone with little vasopressor activity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. Desmopressin is effective in at least one-half of patients and appears to act by increasing the release of large factor VIII:von Willebrand factor multimers from endothelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/30\">",
"     30",
"    </a>",
"    ]. Other factors may include increases in platelet membrane glycoprotein expression [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    dDAVP may be given intravenously or subcutaneously at a dose of 0.3",
"    <span class=\"nowrap\">",
"     microg/kg",
"    </span>",
"    (in 50 mL of saline over 15 to 30 minutes if intravenously) or 3",
"    <span class=\"nowrap\">",
"     microg/kg",
"    </span>",
"    can be given intranasally. The improvement in bleeding time typically begins within about one hour and lasts 4 to 8 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/27\">",
"     27",
"    </a>",
"    ]. Tachyphylaxis typically develops after the second dose, perhaps due to depletion of endothelial stores of the factor VIII:von Willebrand factor multimers. Reduced urine volume and hyponatremia may occur in patients who have urine output.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Correction of anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Raising the hemoglobin to about 10",
"    <span class=\"nowrap\">",
"     g/dl",
"    </span>",
"    or higher will reduce the bleeding time in many patients, occasionally to a normal level [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. The elevation in hemoglobin level can be achieved acutely by red cell transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/33\">",
"     33",
"    </a>",
"    ] or chronically via the administration of recombinant erythropoietic stimulating agents (ESAs) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/32,34\">",
"     32,34",
"    </a>",
"    ]. The improvement in platelet function persists for as long as the hemoglobin remains elevated.",
"    <br/>",
"    <br/>",
"    In addition to improving anemia, ESAs may have a direct beneficial effect on platelet function. Possible mechanisms include increasing the number of glycoprotein",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    molecules on the platelet membrane, improving the defect in thrombin-induced phosphorylation of platelet proteins, and improving platelet calcium signaling [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. However, the administration of ESAs has not been consistently associated with changes in platelet number, enhanced platelet aggregation, increased platelet adhesion to endothelial cells, or changes in concentration of large factor VIII:von Willebrand factor multimers, or other factors. Thus the observed improvement in the bleeding time may be mostly due mostly to rheologic effects described above. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Anemia'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Estrogen",
"    </span>",
"    &nbsp;&mdash;&nbsp;More chronic control of bleeding can be achieved in many uremic patients by the administration of conjugated estrogens (0.6",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    intravenously, daily for five days, 2.5 to 25 mg of Premarin orally per day, or 50 to 100 microg of transdermal estradiol twice weekly) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/38-42\">",
"     38-42",
"    </a>",
"    ]. These agents begin to act on the first day, with peak control reached over five to seven days; the duration of action is one week or more after therapy has been discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/38,40,41\">",
"     38,40,41",
"    </a>",
"    ]. Intravenous estrogens have been recommended as primary therapy rather than oral or transdermal therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/34,38,40,41\">",
"     34,38,40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of estrogens is dose-dependent (ie, the beneficial effect is not seen at doses of 0.3",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/41\">",
"     41",
"    </a>",
"    ] and is primarily mediated by estradiol, acting via the estrogen receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/43\">",
"     43",
"    </a>",
"    ]. The long-term use of this regimen is limited by estrogen-related side effects. It is possible, however, that related compounds with weak estrogenic activity would also be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism by which estrogens act is not well understood but may be due to decreased generation of NO [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Cryoprecipitate",
"    </span>",
"    &nbsp;&mdash;&nbsp;The infusion of cryoprecipitate (10 units intravenously every 12 to 24 hours) can shorten the bleeding time in many uremic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10727/abstract/45\">",
"     45",
"    </a>",
"    ]. The improvement in bleeding time begins within one hour and lasts 4 to 24 hours; it is presumably mediated by the presence in cryoprecipitate of a substance that enhances platelet aggregation, such as factor VIII:von Willebrand factor multimers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/33/9752?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical use of plasma components\", section on 'Cryoprecipitate'",
"    </a>",
"    .) The potential risk of infectious complications from the use of cryoprecipitate has limited use of this modality to patients with life threatening bleeding who are resistant to treatment with dDAVP and blood transfusions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17758614\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Impaired platelet function is a major determinant of uremic bleeding. Bleeding may involve the skin, resulting in easy bruising, or the oral and nasal mucosa, and gingiva. Gastrointestinal bleeding and hematuria may also occur. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical and laboratory manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients may display increased sensitivity to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      , although other coagulation parameters are generally intact. The platelet count is usually normal and there is no prolongation of the prothrombin or partial thromboplastin times unless there is a coexisting coagulopathy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical and laboratory manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Causes of platelet impairment include intrinsic platelet defects, abnormal platelet-endothelial interaction, uremic toxins and anemia. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7703983\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who are actively bleeding or who are about to undergo a surgical procedure should have correction of platelet dysfunction. Treatment options include correction of anemia,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"       desmopressin",
"      </a>",
"      (dDAVP), dialysis, estrogens or cryoprecipitate. Therapies vary in their onset and duration of action. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Raising the hemoglobin to about 10",
"      <span class=\"nowrap\">",
"       g/dl",
"      </span>",
"      may reduce the bleeding time. The improvement in platelet function will persist for as long as the hemoglobin remains elevated. Erythropoietic stimulating agents (ESAs) may also have a direct beneficial effect on platelet function. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Correction of anemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/60/10184?source=see_link\">",
"       Desmopressin",
"      </a>",
"      (dDAVP) provides the simplest and most rapid acute treatment for platelet dysfunction in the uremic patient. Administration of dDAVP at a dose of 0.3",
"      <span class=\"nowrap\">",
"       microg/kg",
"      </span>",
"      given in 50 mL of saline over 15 to 30 minutes intravenously or by subcutaneous injection is preferred; a dose of 3",
"      <span class=\"nowrap\">",
"       microg/kg",
"      </span>",
"      can also be given intranasally. The improvement in bleeding time begins within one hour and lasts 4 to 8 hours. The response to subsequent doses is generally diminished (tachyphylaxis). (See",
"      <a class=\"local\" href=\"#H7704093\">",
"       'Desmopressin (dDAVP)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Either hemodialysis or peritoneal dialysis can partially correct the bleeding time in approximately two-thirds of uremic patients. Hemodialysis should be performed without systemic anticoagulation. (See",
"      <a class=\"local\" href=\"#H7704015\">",
"       'Dialysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prolonged control of bleeding may be achieved by the administration of conjugated estrogens (0.6",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      intravenously, daily for five days, 2.5 to 25 mg of Premarin orally, or 50 to 100 microg of transdermal estradiol twice weekly). These agents begin to act on the first day, with peak control reached over five to seven days; the duration of action is one week or more after therapy has been discontinued. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Estrogen'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The infusion of cryoprecipitate (10 units intravenously every 12 to 24 hours) can shorten the bleeding time in many uremic patients. The improvement in bleeding time begins within one hour and lasts 4 to 24 hours. Potential infectious complications limit the use of cryoprecipitate to patients with life threatening bleeding who are resistant to treatment with dDAVP and blood transfusions. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Cryoprecipitate'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Morgagni, GB. Opera Omnia. Ex Typographia Remondiniana. Venezia, Italy, 1764.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/2\">",
"      RATH CE, MAILLIARD JA, SCHREINER GE. Bleeding tendency in uremia. N Engl J Med 1957; 257:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/3\">",
"      FERGUSON JH, LEWIS JH, ZUCKER MB. Bleeding tendency in uremia. Blood 1956; 11:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/4\">",
"      Molino D, De Lucia D, Gaspare De Santo N. Coagulation disorders in uremia. Semin Nephrol 2006; 26:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/5\">",
"      Gaspari F, Vigan&ograve; G, Orisio S, et al. Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. J Clin Invest 1987; 79:1788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/6\">",
"      Steiner RW, Coggins C, Carvalho AC. Bleeding time in uremia: a useful test to assess clinical bleeding. Am J Hematol 1979; 7:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/7\">",
"      Galbusera M, Remuzzi G, Boccardo P. Treatment of bleeding in dialysis patients. Semin Dial 2009; 22:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/8\">",
"      Eknoyan G, Wacksman SJ, Glueck HI, Will JJ. Platelet function in renal failure. N Engl J Med 1969; 280:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/9\">",
"      Maejima M, Takahashi S, Hatano M. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds]. Nihon Jinzo Gakkai Shi 1991; 33:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/10\">",
"      Escolar G, D&iacute;az-Ricart M, Cases A. Uremic platelet dysfunction: past and present. Curr Hematol Rep 2005; 4:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/11\">",
"      Lee HK, Kim YJ, Jeong JU, et al. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients. Nephron Clin Pract 2010; 114:c248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/12\">",
"      Waki K, Hayashi A, Ikeda S, et al. Measuring platelet aggregation in dialysis patients with a whole blood aggregometer by the screen filtration pressure method. Ther Apher Dial 2011; 15:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/13\">",
"      Marques M, Sacrist&aacute;n D, Mateos-C&aacute;ceres PJ, et al. Different protein expression in normal and dysfunctional platelets from uremic patients. J Nephrol 2010; 23:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/14\">",
"      Weigert AL, Schafer AI. Uremic bleeding: pathogenesis and therapy. Am J Med Sci 1998; 316:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/15\">",
"      Koo JY, Kadonaga JN, Wintroub BV, Lozada-Nur FI. The development of B-cell lymphoma in a patient with psoriasis treated with cyclosporine. J Am Acad Dermatol 1992; 26:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/16\">",
"      Escolar G, Cases A, Bastida E, et al. Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa. Blood 1990; 76:1336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/17\">",
"      Gawaz MP, Dobos G, Sp&auml;th M, et al. Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease. J Am Soc Nephrol 1994; 5:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/18\">",
"      Benigni A, Boccardo P, Galbusera M, et al. Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia. Am J Kidney Dis 1993; 22:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/19\">",
"      Di Minno G, Martinez J, McKean ML, et al. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med 1985; 79:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/20\">",
"      Linthorst GE, Avis HJ, Levi M. Uremic thrombocytopathy is not about urea. J Am Soc Nephrol 2010; 21:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/21\">",
"      Noris M, Remuzzi G. Uremic bleeding: closing the circle after 30 years of controversies? Blood 1999; 94:2569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/22\">",
"      Remuzzi G, Perico N, Zoja C, et al. Role of endothelium-derived nitric oxide in the bleeding tendency of uremia. J Clin Invest 1990; 86:1768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/23\">",
"      Noris M, Benigni A, Boccardo P, et al. Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int 1993; 44:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/24\">",
"      Stewart JH, Castaldi PA. Uraemic bleeding: a reversible platelet defect corrected by dialysis. Q J Med 1967; 36:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/25\">",
"      Nenci GG, Berrettini M, Agnelli G, et al. Effect of peritoneal dialysis, haemodialysis and kidney transplantation on blood platelet function. I. Platelet aggregation by ADP and epinephrine. Nephron 1979; 23:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/26\">",
"      Lindsay RM, Friesen M, Aronstam A, et al. Improvement of platelet function by increased frequency of hemodialysis. Clin Nephrol 1978; 10:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/27\">",
"      Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983; 308:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/28\">",
"      Mannucci PM. Hemostatic drugs. N Engl J Med 1998; 339:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/29\">",
"      Sidawy AN, Spergel LM, Besarab A, et al. The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 2008; 48:2S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/30\">",
"      Zeigler ZR, Megaludis A, Fraley DS. Desmopressin (d-DAVP) effects on platelet rheology and von Willebrand factor activities in uremia. Am J Hematol 1992; 39:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/31\">",
"      Gordz S, Mrowietz C, Pindur G, et al. Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease. Clin Hemorheol Microcirc 2005; 32:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/32\">",
"      Cases A, Escolar G, Reverter JC, et al. Recombinant human erythropoietin treatment improves platelet function in uremic patients. Kidney Int 1992; 42:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/33\">",
"      Livio M, Gotti E, Marchesi D, et al. Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet 1982; 2:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/34\">",
"      Hedges SJ, Dehoney SB, Hooper JS, et al. Evidence-based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol 2007; 3:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/35\">",
"      Diaz-Ricart M, Etebanell E, Cases A, et al. Erythropoietin improves signaling through tyrosine phosphorylation in platelets from uremic patients. Thromb Haemost 1999; 82:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/36\">",
"      Zhou XJ, Vaziri ND. Defective calcium signalling in uraemic platelets and its amelioration with long-term erythropoietin therapy. Nephrol Dial Transplant 2002; 17:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/37\">",
"      van Geet C, Hauglustaine D, Verresen L, et al. Haemostatic effects of recombinant human erythropoietin in chronic haemodialysis patients. Thromb Haemost 1989; 61:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/38\">",
"      Livio M, Mannucci PM, Vigan&ograve; G, et al. Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 1986; 315:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/39\">",
"      Bronner MH, Pate MB, Cunningham JT, Marsh WH. Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure. An uncontrolled trial. Ann Intern Med 1986; 105:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/40\">",
"      Heistinger M, Stockenhuber F, Schneider B, et al. Effect of conjugated estrogens on platelet function and prostacyclin generation in CRF. Kidney Int 1990; 38:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/41\">",
"      Vigan&ograve; G, Gaspari F, Locatelli M, et al. Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia. Kidney Int 1988; 34:853.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/42\">",
"      Sloand JA, Schiff MJ. Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia. Am J Kidney Dis 1995; 26:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/43\">",
"      Vigan&ograve; G, Zoja C, Corna D, et al. 17 beta-estradiol is the most active component of the conjugated estrogen mixture active on uremic bleeding by a receptor mechanism. J Pharmacol Exp Ther 1990; 252:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/44\">",
"      Zoja C, Noris M, Corna D, et al. L-arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia. Lab Invest 1991; 65:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10727/abstract/45\">",
"      Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D. Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 1980; 303:1318.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1947 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-5450C57513-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10727=[""].join("\n");
var outline_f10_30_10727=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17758614\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL AND LABORATORY MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7703983\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Uremic toxins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Nitric oxide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7704015\">",
"      Dialysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7704093\">",
"      Desmopressin (dDAVP)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Correction of anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Estrogen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Cryoprecipitate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17758614\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8410?source=related_link\">",
"      Angiodysplasia of the gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/33/9752?source=related_link\">",
"      Clinical use of plasma components",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=related_link\">",
"      Congenital and acquired disorders of platelet function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/31/20986?source=related_link\">",
"      Gastrointestinal disease in dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/14/38120?source=related_link\">",
"      Hemodialysis anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/11/21690?source=related_link\">",
"      Indications for and complications of renal biopsy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_30_10728="Doppler ultrasound of the umbilical artery for fetal surveillance";
var content_f10_30_10728=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Doppler ultrasound of the umbilical artery for fetal surveillance",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10728/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10728/contributors\">",
"     Dev Maulik, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10728/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10728/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10728/contributors\">",
"     Deborah Levine, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10728/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10728/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/30/10728/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doppler sonography is used for non-invasive assessment of circulation in many clinical conditions. This technique has been used for studying most of the major fetal circulatory systems, including the umbilical artery (UA) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/1\">",
"     1",
"    </a>",
"    ], umbilical vein [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/2\">",
"     2",
"    </a>",
"    ], aorta [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/3\">",
"     3",
"    </a>",
"    ], heart [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/4\">",
"     4",
"    </a>",
"    ], and middle cerebral artery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/5\">",
"     5",
"    </a>",
"    ]. Doppler sonography provides a unique opportunity to investigate human fetal hemodynamics and to use these findings for fetal surveillance.",
"   </p>",
"   <p>",
"    This topic will discuss Doppler sonography of the umbilical artery. In high-risk obstetrical populations, meta-analyses of randomized trials have shown that fetal umbilical artery Doppler is an effective test for improving perinatal mortality and morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSICS OF DOPPLER ULTRASOUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doppler frequency shift refers to the change in frequency of energy wave transmission observed when relative motion occurs between the source of wave transmission and the observer. An ultrasound",
"    <span class=\"nowrap\">",
"     (U/S)",
"    </span>",
"    beam encountering circulating blood is scattered by millions of red cells, which cause the incident beam to undergo a frequency shift proportional to the speed of red cell movement (ie, blood flow velocity). This relationship is expressed in the Doppler equation (",
"    <a class=\"graphic graphic_figure graphicRef56895 \" href=\"UTD.htm?10/17/10515\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/1\">",
"     1",
"    </a>",
"    ]. If the Doppler shift and the angle of beam incidence are known, and assuming that the transducer frequency and the velocity of sound in tissue remain relatively constant, then the velocity of blood flow can be determined from the following modification of the above equation: v = fd.c",
"    <span class=\"nowrap\">",
"     /",
"    </span>",
"    2 ft.cos q [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/2\">",
"     2",
"    </a>",
"    ]. This equation forms the basis for clinical application of the Doppler principle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MODALITIES OF DOPPLER ULTRASOUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical implementations of Doppler ultrasound technology for assessing circulation include continuous wave (CW), pulsed wave (PW), and color Doppler. CW and PW Doppler modes are also known as spectral Doppler. These modalities can also be used to evaluate tissue movement and strain, and are known as tissue Doppler imaging.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Continuous wave",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continuous wave Doppler ultrasound is used extensively in obstetrics for determining and monitoring the fetal heart rate, but cannot identify the exact location of the origin of the Doppler signals in the ultrasound beam path. Free-standing CW devices with a spectral analyzer had been used for insonating the umbilical arteries for velocimetric applications, but PW Doppler has replaced these devices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pulsed wave",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulsed wave Doppler ultrasound allows selection of the desired vascular location for Doppler insonation. Simultaneous real-time two-dimensional dynamic imaging of the fetal anatomy provides the necessary guidance for the targeted Doppler interrogation (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef80085 \" href=\"UTD.htm?36/36/37446\">",
"     image 1",
"    </a>",
"    ). This Doppler mode is essential for confident interrogation of deep vessels and is used extensively in clinical practice. Pulsed wave Doppler is also referred to as duplex Doppler when it is combined with two-dimensional imaging.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Color flow mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;Color Doppler ultrasound flow mapping is based upon the estimation of mean Doppler shifted frequency. It offers real-time depiction of two-dimensional flow patterns superimposed on two-dimensional dynamic images of anatomic structures. Doppler color flow mapping provides qualitative hemodynamic information, including the presence and direction of blood flow. This modality is used for fetal echocardiography (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68631 \" href=\"UTD.htm?26/26/27042\">",
"     image 2",
"    </a>",
"    ) and to investigate other fetal and uterine circulations during pregnancy, as well as pelvic vessels in nonpregnant women.",
"   </p>",
"   <p>",
"    Power Doppler ultrasound exploits the total power in the Doppler signal to produce real-time color-coded images of blood flow. The technique is also termed amplitude Doppler sonography, color Doppler energy (CDE), color amplitude imaging (CAI), and ultrasound angiography. The technique differs from conventional color Doppler in the way the Doppler signals are processed. The colors in the power Doppler image indicate only that blood flow is present, but contain no information on flow velocity or direction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13803321\">",
"    <span class=\"h2\">",
"     Tissue Doppler imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue Doppler imaging analyzes Doppler frequency shifts generated by tissue movement or strain, as seen in myocardium during the cardiac cycle. In contrast to Doppler ultrasound for assessing blood circulation, the Doppler signals generated by tissue movements and strain are substantially higher in amplitude and lower in frequency. The method has been used to assess directly global and regional myocardial function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SAFETY IN PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27592?source=see_link\">",
"     \"Basic principles and safety of diagnostic ultrasound in obstetrics and gynecology\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DOPPLER WAVEFORM ANALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doppler ultrasound waveforms reflect blood velocity; therefore, they potentially can yield information on various aspects of blood flow in a circulation, including the presence and direction of flow, velocity profile, volume of flow, and impedance to flow. In perinatal practice, Doppler of the umbilical artery has been used extensively for assessing downstream circulatory impedance (ie, resistance to pulsatile flow).",
"   </p>",
"   <p>",
"    Doppler waveform analysis is usually based upon the following characteristics of the maximum frequency shift envelope (",
"    <a class=\"graphic graphic_figure graphicRef73657 \" href=\"UTD.htm?9/34/9774\">",
"     figure 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Peak systolic frequency shift value (S)",
"     </li>",
"     <li>",
"      End-diastolic frequency shift value (D)",
"     </li>",
"     <li>",
"      Average frequency shift value over the cardiac cycle (A)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These three values are used to develop indices that measure the pulsatility of the Doppler waveform reflecting the dynamic changes in the circulation through the cardiac cycle. A Doppler index (DI) is calculated as a ratio and is, therefore, virtually independent of the angle of insonation, thus obviating the need for measuring the angle.",
"   </p>",
"   <p>",
"    The most commonly used obstetrical applications are the peak systolic frequency shift to end-diastolic frequency shift ratio,",
"    <span class=\"nowrap\">",
"     (S/D)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/7\">",
"     7",
"    </a>",
"    ] and the resistance index (RI), which represents the difference between the peak systolic and end-diastolic shift divided by the peak systolic shift [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/8\">",
"     8",
"    </a>",
"    ]. The interobserver and intraobserver variances for the",
"    <span class=\"nowrap\">",
"     S/D",
"    </span>",
"    ratio are 9.8 and 11.1 percent, respectively, and for the RI, 4 and 8 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/9\">",
"     9",
"    </a>",
"    ]. The pulsatility index (PI =",
"    <span class=\"nowrap\">",
"     S-D/A)",
"    </span>",
"    is also used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Factors affecting the waveform",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gestational age &mdash; The end-diastolic velocity increases with advancing gestation, which is consistent with the progressive decline in fetoplacental blood flow impedance from fetal and placental vascular and hemodynamic changes. This is reflected by the continuing decline in the",
"      <span class=\"nowrap\">",
"       S/D",
"      </span>",
"      ratio and RI as pregnancy advances (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef68103 \" href=\"UTD.htm?1/22/1383\">",
"       image 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Uteroplacental insufficiency &mdash; Pregnancy complications such as fetal growth restriction (FGR) and preeclampsia, which are characterized by rising impedance in the fetoplacental vascular bed (see below), show a decline in the end-diastolic velocity and an increase in these Doppler indices.",
"     </li>",
"     <li>",
"      Fetal heart rate &mdash; The fetal heart rate can effect Doppler indices [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. However, within the normal limits of the fetal heart rate (120 to 160 bpm), the changes in the Doppler indices are not significant.",
"     </li>",
"     <li>",
"      Fetal breathing &mdash; Substantial changes in intrathoracic pressure and central hemodynamics occur during fetal breathing [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/12\">",
"       12",
"      </a>",
"      ]. These changes produce dynamic variability in the Doppler waveform and, therefore, in the Doppler indices. Therefore, Doppler interrogation of the UA should only be performed during fetal apnea.",
"     </li>",
"     <li>",
"      Fetal behavioral states &mdash; Indices do not appear to be affected by fetal behavioral states [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/13,14\">",
"       13,14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Measurement technique &mdash; Technical factors that affect waveform analysis include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Location where the cord is sampled &mdash; The indices are higher at the fetal than at the placental end of the cord [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/11\">",
"       11",
"      </a>",
"      ]. For PW Doppler, a mid-level free floating loop of the cord should be used for sampling when the site of Doppler sampling can be selected. Others recommend using the fetal end of the umbilical cord [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/15\">",
"       15",
"      </a>",
"      ]. The clinical significance of these variations in measurement technique remains unclear.",
"     </li>",
"     <li>",
"      Angle of insonation &ndash; The angle between the Doppler ultrasound beam path (as indicated by cursor line in the two dimensional image) and the axis of the blood vessel will affect the Doppler frequency shift and therefore the size of the waveform. The higher the angle, the smaller the waveform. Although the Doppler indices are almost completely angle independent, it is preferable to keep the angle of insonation as close to zero as possible (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Procedure'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Wall filter setting &ndash; The wall filter removes high amplitude low frequency Doppler signals generated by the vascular wall movements from the total Doppler flow signals. However, a higher filter setting may also remove low frequency umbilical artery flow signals during the end diastole. Therefore, the wall filter should be kept as low as achievable for the specific ultrasound device.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CORRELATION BETWEEN DOPPLER, ANATOMIC, AND CLINICAL FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Analysis of Doppler waveforms from an arterial source yields information about downstream impedance to flow [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/16\">",
"     16",
"    </a>",
"    ]. The Doppler index (DI) worsens with increasing pathology of the fetoplacental vascular system.",
"   </p>",
"   <p>",
"    Abnormal fetal placental angiogenesis characterized by sparse, elongated, uncoiled, and less ramified terminal capillary loops, as well as other histological changes, are seen in pregnancies complicated by growth restriction and abnormal umbilical arterial Doppler [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/17-20\">",
"     17-20",
"    </a>",
"    ]. These observations suggest fetoplacental vascular maldevelopment results in an increase in impedance that is reflected in the abnormal Doppler waveforms and indices. Embolization studies in sheep fetuses have shown that an increase in the umbilical artery Doppler index becomes apparent only when the flow is substantially reduced. A change in the Doppler waveform precedes any changes in the fetal heart rate patterns, even with progressive metabolic acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Obstetrical complications, such as FGR and preeclampsia, result in chronic fetal nutritive and respiratory deprivation. As the stress intensifies",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lengthens, the fetus mobilizes defensive responses that include preferential preservation of fetal growth over placental growth, changes in fetal movement pattern, deceleration of the fetal growth rate, and, eventually, chronic hypoxia and acidosis (",
"    <a class=\"graphic graphic_figure graphicRef56906 \" href=\"UTD.htm?10/20/10566\">",
"     figure 3",
"    </a>",
"    ). The primary fetal hemodynamic response to this deprivation involves redistribution of blood flow to the brain, heart, adrenals, and placenta at the expense of flow to muscles, viscera, skin, and other less critical tissues and organs [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/23\">",
"     23",
"    </a>",
"    ]. Changes in blood flow impedance in the fetal regional circulations underlie this phenomenon. Doppler ultrasound demonstrates these circulatory changes associated with fetal compromise and allows perinatal prognostication.",
"   </p>",
"   <p>",
"    The sequence of changes in fetal heart rate, Doppler findings, and other biophysical parameters during progressive fetal compromise reflect the fetal homeostatic response to chronic hypoxia (",
"    <a class=\"graphic graphic_figure graphicRef56906 \" href=\"UTD.htm?10/20/10566\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/24\">",
"     24",
"    </a>",
"    ]. Abnormal elevation of Doppler indices precedes loss of fetal heart rate variability and reactivity, eventually leading to decline and loss of fetal breathing and body movements [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Reversed end diastolic velocity in the umbilical artery, absence or reversed atrial wave in the ductus venosus, and rapid loss of heart rate variability portend a poor outcome. Agonal signs and death occur if there are no interventions. This progression may provide the basis for determining the sequence of fetal testing in clinical practice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     AEDV AND REDV",
"    </span>",
"    &nbsp;&mdash;&nbsp;The end-diastolic component of the Doppler waveform is crucial for assessing fetal well-being. Absence of end-diastolic flow velocity (AEDV) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73059 \" href=\"UTD.htm?19/47/20214\">",
"     image 4",
"    </a>",
"    ) or reversal of end-diastolic flow velocity (REDV) is associated with markedly adverse perinatal outcome, particularly a high perinatal mortality rate (",
"    <a class=\"graphic graphic_table graphicRef70766 \" href=\"UTD.htm?0/62/1004\">",
"     table 1",
"    </a>",
"    ) with a higher prevalence of chromosomal abnormalities (especially trisomy 13, 18, and 21) and congenital anomalies (",
"    <a class=\"graphic graphic_table graphicRef64316 \" href=\"UTD.htm?13/35/13884\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/27-32\">",
"     27-32",
"    </a>",
"    ]. These relationships are illustrated by the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A European multicenter study involving 245 fetuses with AEDV or REDV reported a perinatal mortality rate of 28 percent, and 96 to 98 percent of the infants required intensive care [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/31\">",
"       31",
"      </a>",
"      ]. The risk of cerebral hemorrhage, anemia, and hypoglycemia was also increased.",
"     </li>",
"     <li>",
"      A review including 1126 cases of AEDV reported in the literature calculated a stillbirth rate of 170 per 1000 and neonatal mortality rate of 280 per 1000 [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/32\">",
"       32",
"      </a>",
"      ]. Most of the deaths were related to growth restriction, prematurity, fetal anomalies, and aneuploidy. The perinatal mortality rate corrected for congenital malformations and chromosomal abnormalities was approximately 340 per 1000 births.",
"     </li>",
"     <li>",
"      A prospective observational study including 113 pregnancies complicated by fetal growth restriction examined the relationship between neurodevelopmental outcome at age 2 and umbilical artery Doppler, ductus venosus Doppler, middle cerebral artery Doppler, as well as the biophysical profile score and several other indicators. Only reverse flow in the umbilical artery, gestational age, and birth weight independently predicted neurodevelopmental delay [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The frequency of AEDV is approximately 2 percent in well-defined high risk pregnancies and may be as low as 0.3 percent in a general obstetrical population. AEDV may improve over time, although often only transiently, and days to weeks may elapse before the fetus shows additional evidence of compromise, especially in preterm pregnancies. Thus, this finding is not necessarily an immediate indication for delivery in pregnancies before 34 weeks if fetal surveillance tests, such as the nonstress test or biophysical profile, are reassuring (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Guidelines for clinical practice'",
"    </a>",
"    below). Although delivery after 32 completed weeks of gestation has been recommended, there are continuing concerns about prematurity risks before 34 completed weeks of gestation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL EFFECTIVENESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Twenty randomized clinical trials on fetal Doppler sonography involving a total population of 24,779 women have been reported. These trials have been reviewed elsewhere [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/34\">",
"     34",
"    </a>",
"    ]. Most of the trials were performed in high risk pregnancies and showed improved outcome despite inadequate sample size for a single study, heterogeneity in the patient population, study design, and study objectives. Several meta-analyses and systematic reviews of these trials have been performed. The most recent Cochrane review of 18 trials involving 10,225 women found a 29 percent decline in perinatal mortality, which was statistically significant (RR 0.71,95% CI 0.52-0.98) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/35\">",
"     35",
"    </a>",
"    ]. This meant that 203 high risk pregnancies needed to be treated to prevent one perinatal death. Additional benefits included fewer inductions and cesarean deliveries. This evidence of clinical effectiveness makes umbilical Doppler unique among fetal surveillance tests.",
"   </p>",
"   <p>",
"    The benefit of Doppler surveillance primarily pertained to pregnancies complicated by fetal growth restriction or preeclampsia. It may also be useful for fetal surveillance in twin gestations complicated by growth restriction, discordancy, or monochorionicity. Well-designed trials in other populations are needed.",
"   </p>",
"   <p>",
"    In contrast to high risk pregnancies, trials of UA Doppler as a screening test in low risk pregnancies did",
"    <strong>",
"     NOT",
"    </strong>",
"    show any improvement in pregnancy outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/36\">",
"     36",
"    </a>",
"    ]. As an example, a multicenter French randomized trial in 4187 low risk pregnant mothers failed to observe any improvements in the outcome with routine UA Doppler sonography between 28 and 34 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     GUIDELINES FOR CLINICAL PRACTICE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principles of managing a high risk pregnancy utilizing UA Doppler velocimetry in conjunction with other fetal surveillance test findings are described below. These recommendations are based upon current evidence and should be used to guide patient management with individualization of care as dictated by the specific clinical circumstance (",
"    <a class=\"graphic graphic_algorithm graphicRef79980 \" href=\"UTD.htm?30/29/31198\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Umbilical artery Doppler assessment is most useful in pregnancies complicated by fetal growth restriction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    preeclampsia. Doppler velocimetry is recommended as a primary surveillance tool for monitoring these pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/38\">",
"     38",
"    </a>",
"    ]. Doppler investigation identifies the fetal cardiovascular response to progressive hypoxia and acidosis and assists in discriminating small, but constitutionally normal, fetuses from those compromised by placental insufficiency. The use of Doppler in management of pregnancies complicated by FGR is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23994?source=see_link&amp;anchor=H7#H7\">",
"     \"Fetal growth restriction: Evaluation and management\", section on 'Doppler velocimetry'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Umbilical artery Doppler is also used in surveillance of some twin pregnancies, especially in the setting of discordant twin growth and twin transfusion syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient should be counseled regarding the relevant aspects of the test. She is placed in a semi-recumbent position, with lateral tilt to avoid maternal inferior vena caval compression. The wall filter settings for pulsed Doppler are kept at the lowest level (approximately 50 to 100 Hz) to prevent any false depiction of low or absent end-diastolic flow. An initial ultrasound examination is performed to confirm that the fetus is not active, breathing, or hiccupping, and to identify a free-floating loop of cord for sampling. Color Doppler may assist in identifying the sampling site. The Doppler cursor line should be aligned with the vessel axis with the angle of insonation as close to zero as possible. The Doppler sample volume is then placed in the vascular lumen encompassing it and the waveforms are recorded (",
"    <a class=\"graphic graphic_movie graphicRef87280 \" href=\"UTD.htm?22/60/23488\">",
"     movie 1",
"    </a>",
"    ). The peak systolic and end diastolic frequency shifts are then identified with cursors and the Doppler indices are generated. Many devices can semi-automatically generate the indices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Clinical interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;An",
"    <span class=\"nowrap\">",
"     S/D",
"    </span>",
"    ratio &gt;3.0 or RI &gt;0.6 has the best discriminatory ability in high risk pregnancies 28 or more completed weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/39\">",
"     39",
"    </a>",
"    ]. The utility of this technique before 28 weeks for fetal surveillance in high risk pregnancies remains investigational.",
"   </p>",
"   <p>",
"    A gestational age-specific nomogram may also be used, although such nomograms have not been standardized. In general, a DI below the 95th centile for the gestational age should be considered assuring. An initially high",
"    <span class=\"nowrap\">",
"     S/D",
"    </span>",
"    ratio may progressively decline with advancing gestation, signifying an improved prognosis. In contrast, a rising UA DI may indicate worsening fetal prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most important diagnostic characteristic of the UA Doppler waveform is the state of the end diastolic velocity. As discussed above, AEDV is an ominous finding and should indicate delivery in pregnancies beyond 34 completed weeks. REDV has an even worse prognosis and should be interpreted as a preterminal finding. We feel its presence should indicate immediate delivery as early as 28 weeks of gestation. These principles are discussed in detail below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Management with normal Doppler indices",
"    </span>",
"    &nbsp;&mdash;&nbsp;High risk pregnancies (eg, FGR or preeclampsia) with a DI that remains normal or is not progressively rising should be followed with weekly Doppler evaluation. We use the nonstress test (NST) or biophysical profile (BPP) as either a backup test or simultaneously with the UA Doppler. We prefer the latter approach, as progressive fetal compromise involves response from many fetal systems that may be more amenable to multimodal fetal surveillance.",
"   </p>",
"   <p>",
"    Fetal monitoring should be intensified if there is a worsening of the clinical status (eg, progressive restriction of growth or severity of preeclampsia), and appropriate obstetrical intervention according to the existing standards of practice should be implemented. If the fetal and the maternal evaluations remain reassuring, then the pregnancy can continue to 38 to 40 weeks, at which time delivery should occur. Growth restricted pregnancies should not continue beyond 40 weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Management with abnormal Doppler indices",
"    </span>",
"    &nbsp;&mdash;&nbsp;The obstetrical management when the DI is abnormal depends upon the severity of the Doppler abnormality, severity of the underlying obstetrical complication, and the duration of gestation. Fetal malformations and aneuploidy are additional factors; management should be individualized in their presence. The following algorithm represents our approach for using UA Doppler in conjunction with other modalities of fetal surveillance for managing fetal growth restriction (",
"    <a class=\"graphic graphic_algorithm graphicRef79980 \" href=\"UTD.htm?30/29/31198\">",
"     algorithm 1",
"    </a>",
"    ). &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A high or increasing DI in the presence of end-diastolic flow warrants more intensive fetal surveillance, such as weekly umbilical Doppler ultrasound and once or twice per week NST, BPP, or modified BPP, as dictated by the clinical condition. If fetal surveillance tests indicate fetal compromise (eg, nonreactive NST, poor fetal heart rate baseline variability, persistent late decelerations, oligohydramnios, or BPP score &lt;4), delivery should be strongly considered, with the mode of delivery determined by obstetrical factors (eg, gestational age, presentation, fetal heart rate tracing) and maternal factors (eg, medical complications, cervical status).",
"     </li>",
"     <li>",
"      AEDV or REDV is associated with increased likelihood of poor perinatal outcome. Therefore, an urgent clinical response is indicated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The specific management of severe DI abnormalities depends upon the gestational age. The optimal timing for delivery in very preterm pregnancies with abnormal Doppler indices remains uncertain. One trial involving high risk early preterm pregnancies failed to resolve this issue, as no significant differences were noted in the deaths before discharge from the hospital between early versus delayed delivery groups [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/41\">",
"     41",
"    </a>",
"    ]. In a follow-up study, no important differences in mortality or in the developmental assessment were seen at or beyond two years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10728/abstract/42\">",
"     42",
"    </a>",
"    ]. However, a difference in disability was observed in gestations below 31 weeks of gestation at randomization, which prompted the investigators to caution against delivering before 30 weeks.",
"   </p>",
"   <p>",
"    We feel the development of AEDV should prompt immediate consideration of delivery if the gestation is beyond 34 completed weeks. With advances in neonatal care, fetal risks from lung immaturity during this gestational period are considered less than those from in-utero asphyxia. The management is more conservative in a more preterm pregnancy (&le;34 weeks) when fetal pulmonary immaturity presents a greater risk. In this circumstance, fetal well-being should be assessed",
"    <strong>",
"     daily",
"    </strong>",
"    with UA Doppler, NST, BPP, or modified BPP.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/5/44120?source=see_link\">",
"     Betamethasone",
"    </a>",
"    should be given to enhance fetal lung maturity. Delivery is indicated when one or more of these tests indicate imminent fetal danger, irrespective of maturity.",
"   </p>",
"   <p>",
"    The presence of REDV at any gestational age beyond 28 weeks should prompt immediate delivery. Some experts would consider continuously monitoring these fetuses and giving a course of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/5/44120?source=see_link\">",
"     betamethasone",
"    </a>",
"    prior to delivery. Use of venous Doppler appears to improve the prediction of stillbirth and acidemia when arterial Doppler has identified a fetus at risk. This is the next step in the evaluation of these fetuses and may help to identify fetuses who require immediate delivery versus those in whom delivery can be delayed for a course of steroids. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14217?source=see_link\">",
"     \"Venous Doppler for fetal assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In general, cesarean delivery is a reasonable choice in most cases of AEDV, as fetal tolerance to labor is poor in this situation. Cesarean delivery is clearly indicated in the presence of REDV or ominous fetal monitoring findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Doppler velocimetry of the umbilical artery (UA) provides a noninvasive measure of the fetoplacental hemodynamic state. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Doppler waveform analysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      UA Doppler indices indirectly reflect impedance of downstream circulation. Abnormality of the Doppler index has been correlated to fetoplacental vascular maldevelopment. There is a significant association between abnormal Doppler indices and fetal hypoxia, fetal acidosis, and adverse perinatal outcome. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Correlation between Doppler, anatomic, and clinical findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most randomized trials of UA Doppler ultrasound in high risk pregnancies show improved outcome when this technique is used in pregnancies complicated by growth restriction or preeclampsia. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Clinical effectiveness'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical management should integrate the Doppler approach with existing modalities of antepartum fetal monitoring. The most important diagnostic characteristic of the UA Doppler waveform is the state of the end diastolic velocity: absent end-diastolic velocity (AEDV) is an ominous finding and reversed end-diastolic velocity (REDV) should be interpreted as a preterminal finding. In pregnancies complicated by fetal growth restriction or preeclampsia at &ge;34 weeks of gestation, we recommend prompt delivery rather than expectant management in the setting of AEDV or REDV (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Guidelines for clinical practice'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/1\">",
"      FitzGerald DE, Drumm JE. Non-invasive measurement of human fetal circulation using ultrasound: a new method. Br Med J 1977; 2:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/2\">",
"      Gill RW. Pulsed Doppler with B-mode imaging for quantitative blood flow measurement. Ultrasound Med Biol 1979; 5:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/3\">",
"      Eik-Nes, SH, Brubakk, AO, et al. Measurement of human fetal blood flow. Br Med J 1980; 28:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/4\">",
"      Maulik D, Nanda NC, Saini VD. Fetal Doppler echocardiography: methods and characterization of normal and abnormal hemodynamics. Am J Cardiol 1984; 53:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/5\">",
"      Arbeille, P, Tranquart, F, Body, G, et al. Evolution de la circulation arterielle ombilicale et cerebrale du foctus au cours de la grossesse. Progres en Neonatologie 1986; 6:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/6\">",
"      Maulik D, Mundy D, Heitmann E, Maulik D. Evidence-based approach to umbilical artery Doppler fetal surveillance in high-risk pregnancies: an update. Clin Obstet Gynecol 2010; 53:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/7\">",
"      Stuart B, Drumm J, FitzGerald DE, Duignan NM. Fetal blood velocity waveforms in normal pregnancy. Br J Obstet Gynaecol 1980; 87:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/8\">",
"      Pourcelot, L. Applications clinique de 1'examen Doppler transcutane In: Pourcelot, L(Ed): Velocimetric Ultrasonore Doppler 1974; 34:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/9\">",
"      Maulik D, Yarlagadda AP, Youngblood JP, Willoughby L. Components of variability of umbilical arterial Doppler velocimetry--a prospective analysis. Am J Obstet Gynecol 1989; 160:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/10\">",
"      Mires G, Dempster J, Patel NB, Crawford JW. The effect of fetal heart rate on umbilical artery flow velocity waveforms. Br J Obstet Gynaecol 1987; 94:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/11\">",
"      Yarlagadda P, Willoughby L, Maulik D. Effect of fetal heart rate on umbilical arterial Doppler indices. J Ultrasound Med 1989; 8:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/12\">",
"      Abramowicz JS, Warsof SL, Arrington J, Levy DL. Doppler analysis of the umbilical artery. The importance of choosing the placental end of the cord. J Ultrasound Med 1989; 8:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/13\">",
"      van Eyck J, Wladimiroff JW, van den Wijngaard JA, et al. The blood flow velocity waveform in the fetal internal carotid and umbilical artery; its relation to fetal behavioural states in normal pregnancy at 37-38 weeks. Br J Obstet Gynaecol 1987; 94:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/14\">",
"      van Eyck J, Wladimiroff JW, Noordam MJ, et al. The blood flow velocity waveform in the fetal descending aorta; its relationship to behavioural states in the growth-retarded fetus at 37-38 weeks of gestation. Early Hum Dev 1986; 14:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/15\">",
"      Society for Maternal-Fetal Medicine Publications Committee, Berkley E, Chauhan SP, Abuhamad A. Doppler assessment of the fetus with intrauterine growth restriction. Am J Obstet Gynecol 2012; 206:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/16\">",
"      Maulik D. Hemodynamic interpretation of the arterial Doppler waveform. Ultrasound Obstet Gynecol 1993; 3:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/17\">",
"      Krebs C, Macara LM, Leiser R, et al. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 1996; 175:1534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/18\">",
"      Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000; 92:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/19\">",
"      Salafia CM, Pezzullo JC, Minior VK, Divon MY. Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses. Obstet Gynecol 1997; 90:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/20\">",
"      Spinillo A, Gardella B, Bariselli S, et al. Placental histopathological correlates of umbilical artery Doppler velocimetry in pregnancies complicated by fetal growth restriction. Prenat Diagn 2012; 32:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/21\">",
"      Morrow RJ, Adamson SL, Bull SB, Ritchie JW. Effect of placental embolization on the umbilical arterial velocity waveform in fetal sheep. Am J Obstet Gynecol 1989; 161:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/22\">",
"      Wilcox GR, Trudinger BJ, Cook CM, et al. Reduced fetal platelet counts in pregnancies with abnormal Doppler umbilical flow waveforms. Obstet Gynecol 1989; 73:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/23\">",
"      Peeters LL, Sheldon RE, Jones MD Jr, et al. Blood flow to fetal organs as a function of arterial oxygen content. Am J Obstet Gynecol 1979; 135:637.",
"     </a>",
"    </li>",
"    <li>",
"     Visser, GH, Stigter, RH. Monitoring the growth retarded fetus. In Asphyxia and Fetal Brain Damage. Maulik, D (Ed), Springer International, New York 1997. p. 333.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/25\">",
"      Ribbert LS, Visser GH, Mulder EJ, et al. Changes with time in fetal heart rate variation, movement incidences and haemodynamics in intrauterine growth retarded fetuses: a longitudinal approach to the assessment of fetal well being. Early Hum Dev 1993; 31:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/26\">",
"      Williams KP, Farquharson DF, Bebbington M, et al. Screening for fetal well-being in a high-risk pregnant population comparing the nonstress test with umbilical artery Doppler velocimetry: a randomized controlled clinical trial. Am J Obstet Gynecol 2003; 188:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/27\">",
"      Bilardo CM, Nicolaides KH, Campbell S. Doppler measurements of fetal and uteroplacental circulations: relationship with umbilical venous blood gases measured at cordocentesis. Am J Obstet Gynecol 1990; 162:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/28\">",
"      Yoon BH, Romero R, Roh CR, et al. Relationship between the fetal biophysical profile score, umbilical artery Doppler velocimetry, and fetal blood acid-base status determined by cordocentesis. Am J Obstet Gynecol 1993; 169:1586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/29\">",
"      Valcamonico A, Danti L, Frusca T, et al. Absent end-diastolic velocity in umbilical artery: risk of neonatal morbidity and brain damage. Am J Obstet Gynecol 1994; 170:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/30\">",
"      Soothill PW, Nicolaides KH, Bilardo K, et al. Utero-placental blood velocity resistance index and umbilical venous pO2, pCO2, pH, lactate and erythroblast count in growth-retarded fetuses. Fetal Ther 1986; 1:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/31\">",
"      Karsdorp VH, van Vugt JM, van Geijn HP, et al. Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet 1994; 344:1664.",
"     </a>",
"    </li>",
"    <li>",
"     Maulik, D, Absent End Diastolic Velocity In The Umbilical Artery And Its Clinical Significance. In: Doppler Ultrasound in Obstetrics and Gynecology, 2nd ed, Maulik, D (Ed), Springer-Verlag, New York 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/33\">",
"      Gratac&oacute;s E. The problem of predicting neurological outcome in early-onset intrauterine growth restriction. Ultrasound Obstet Gynecol 2009; 33:5.",
"     </a>",
"    </li>",
"    <li>",
"     Maulik, D, Figueroa, R. Doppler velocimetry for fetal surveillance: randomized clinical trials and implications for practice. In: Doppler Ultrasound in Obstetrics and Gynecology, Maulik D.  (Ed), Springer, 2005. p.387.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/35\">",
"      Alfirevic Z, Stampalija T, Gyte GM. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev 2010; :CD007529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/36\">",
"      Bricker L, Neilson JP. Routine doppler ultrasound in pregnancy. Cochrane Database Syst Rev 2000; :CD001450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/37\">",
"      A randomised controlled trial of Doppler ultrasound velocimetry of the umbilical artery in low risk pregnancies. Doppler French Study Group. Br J Obstet Gynaecol 1997; 104:419.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Intrauterine growth restriction. ACOG Practice Bulletin 12. American College of Obstetricians and Gynecologists, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/39\">",
"      Maulik D, Yarlagadda P, Youngblood JP, Ciston P. The diagnostic efficacy of the umbilical arterial systolic/diastolic ratio as a screening tool: a prospective blinded study. Am J Obstet Gynecol 1990; 162:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/40\">",
"      Devoe LD, Gardner P, Dear C, Faircloth D. The significance of increasing umbilical artery systolic-diastolic ratios in third-trimester pregnancy. Obstet Gynecol 1992; 80:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/41\">",
"      GRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG 2003; 110:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10728/abstract/42\">",
"      Thornton JG, Hornbuckle J, Vail A, et al. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004; 364:513.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 459 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-122.72.76.133-518C2F532B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10728=[""].join("\n");
var outline_f10_30_10728=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSICS OF DOPPLER ULTRASOUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MODALITIES OF DOPPLER ULTRASOUND",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Continuous wave",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pulsed wave",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Color flow mapping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13803321\">",
"      Tissue Doppler imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SAFETY IN PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DOPPLER WAVEFORM ANALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Factors affecting the waveform",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CORRELATION BETWEEN DOPPLER, ANATOMIC, AND CLINICAL FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      AEDV AND REDV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL EFFECTIVENESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      GUIDELINES FOR CLINICAL PRACTICE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Procedure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Clinical interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Management with normal Doppler indices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Management with abnormal Doppler indices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/459\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/459|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?30/29/31198\" title=\"algorithm 1\">",
"      Clinical protocol for fetal umbilical artery surveillance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/459|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/36/37446\" title=\"diagnostic image 1\">",
"      Duplex pulsed doppler sonogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/26/27042\" title=\"diagnostic image 2\">",
"      Color Doppler flow mapping of right and left ventricular outflow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/22/1383\" title=\"diagnostic image 3\">",
"      Effect of gestational age on UA Doppler indices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/47/20214\" title=\"diagnostic image 4\">",
"      Absent diastolic flow",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/459|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/17/10515\" title=\"figure 1\">",
"      Principles of Doppler sonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/34/9774\" title=\"figure 2\">",
"      Derivation Doppler indices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/20/10566\" title=\"figure 3\">",
"      Fetal response to stress",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/459|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?22/60/23488\" title=\"movie 1\">",
"      Doppler ultrasound of the umbilical artery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/459|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/62/1004\" title=\"table 1\">",
"      Diastolic vel and preg outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/35/13884\" title=\"table 2\">",
"      Cong malformat and absent EDV",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27592?source=related_link\">",
"      Basic principles and safety of diagnostic ultrasound in obstetrics and gynecology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23994?source=related_link\">",
"      Fetal growth restriction: Evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14217?source=related_link\">",
"      Venous Doppler for fetal assessment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_30_10729="Clinical manifestations and diagnosis of Chlamydia trachomatis infections";
var content_f10_30_10729=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of Chlamydia trachomatis infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10729/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10729/contributors\">",
"     Jeanne Marrazzo, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10729/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10729/contributors\">",
"     Noreen A Hynes, MD, MPH, DTM&amp;H",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10729/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10729/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/30/10729/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H22688556\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chlamydia trachomatis is the most common bacterial cause of sexually transmitted genital infections [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/1\">",
"     1",
"    </a>",
"    ]. The majority of affected persons are asymptomatic, and thus provide an ongoing reservoir for infection. In infants born to mothers through an infected birth canal, conjunctivitis and pneumonia can occur. Moreover, both men and women can experience clinical syndromes due to infection at common epithelial sites, including the rectum and conjunctivae. Other types of C. trachomatis infection, including lymphogranuloma venereum and endemic trachoma, an ocular infection spread by direct contact and seen commonly in the developing world, may occur in both men and women.",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of Chlamydia trachomatis in women and men are discussed below. Screening for and treatment of Chlamydia trachomatis as well as neonatal Chlamydia trachomatis infection, lymphogranuloma venereum, and endemic trachoma are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8408?source=see_link\">",
"     \"Screening for Chlamydia trachomatis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=see_link\">",
"     \"Treatment of Chlamydia trachomatis infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/21/27992?source=see_link\">",
"     \"Chlamydia trachomatis infections in the newborn\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/36/21063?source=see_link\">",
"     \"Lymphogranuloma venereum\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8409?source=see_link\">",
"     \"Epidemiology, diagnosis, and management of trachoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688563\">",
"    <span class=\"h1\">",
"     CLINICAL SYNDROMES IN WOMEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the majority of women with C. trachomatis infection are asymptomatic, the pathogen is an important cause of several common clinical syndromes, discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9967428\">",
"    <span class=\"h2\">",
"     Genital infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women, the cervix is the most commonly infected anatomic site [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/2\">",
"     2",
"    </a>",
"    ], and a proportion of women may also have infection of the urethra. Untreated, cervical infection can ascend to cause pelvic inflammatory disease and its sequelae of infertility and chronic pain. Pregnant women with genital chlamydial infection are also at high risk for complications.",
"   </p>",
"   <p>",
"    In addition, the presence of cervical ectopy (namely, the presence of columnar epithelium on the outer surface of the cervix in addition to in the endocervical canal) has been epidemiologically associated with an increased risk of detection of chlamydial infection. Some investigators have reported a link between infection and subsequent risk of cervical neoplasia; the extent of this potential effect at the population level is not known [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688570\">",
"    <span class=\"h3\">",
"     Cervicitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority (at least 85 percent) of women infected at the cervix have neither signs nor symptoms, which is the rationale for routine annual screening of young sexually active women. As an example, in a multinational study of high-risk women who were screened for genital chlamydial infection with polymerase chain reaction testing of vaginal swabs, four of five sites recorded symptoms in only 6 to 14 percent of those who developed a new infection within the first year of testing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/4\">",
"     4",
"    </a>",
"    ]. When symptoms do occur, they are highly nonspecific, and can easily be confused with vaginitis or endometrial pathology: a change in vaginal discharge, intermenstrual vaginal bleeding, and post-coital bleeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/4/64?source=see_link&amp;anchor=H112758544#H112758544\">",
"     \"Acute cervicitis\", section on 'Signs and symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similarly, abnormal exam findings are found in the minority of women with genital chlamydial infection, approximately 10 to 20 percent in some studies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. When signs are present, they include classic findings of cervicitis: mucopurulent endocervical discharge (",
"    <a class=\"graphic graphic_picture graphicRef67848 \" href=\"UTD.htm?35/17/36114\">",
"     picture 1",
"    </a>",
"    ), easily induced endocervical bleeding, or edematous ectopy (",
"    <a class=\"graphic graphic_picture graphicRef84032 \" href=\"UTD.htm?22/13/22738\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/4/64?source=see_link&amp;anchor=H5#H5\">",
"     \"Acute cervicitis\", section on 'Physical examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The incubation period of symptomatic disease generally ranges from 7 to 14 days following infection. However, it is unclear how long those with asymptomatic disease may carry the infection. In a systematic review of ten studies of untreated, uncomplicated genital chlamydial infections, detection of chlamydia persisted over the short term (weeks to months after diagnosis) in 56 to 89 percent, and for at least one year in 46 to 57 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/7\">",
"     7",
"    </a>",
"    ]. However, these studies did not record infection date nor did they evaluate for reinfection as opposed to persistent infection, thus limiting the understanding of duration of untreated chlamydial infection. Nevertheless, despite the possibility of spontaneous resolution, all women diagnosed with chlamydia should be treated to prevent further complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=see_link\">",
"     \"Treatment of Chlamydia trachomatis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9967056\">",
"    <span class=\"h3\">",
"     Dysuria-pyuria syndrome due to urethritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chlamydial infection of the female urethra typically occurs in a relatively small proportion (approximately 25 percent) of women with cervical infection. Most of these women do not report symptoms specific to the urethral tract, but some complain of typical symptoms of a urinary tract infection (UTI) such as frequency and dysuria. Urinalysis reveals pyuria, but bacteriuria is absent on dipstick analysis, and no organisms are seen on Gram stain or in bacterial culture. This combination of pyuria but no bacteriuria in a young, sexually active woman should prompt strong suspicion for chlamydial infection of the urethra. The differential diagnosis for such a presentation includes low-colony count urinary tract infection (eg, infection caused by Staphylococcus saprophyticus), or urethritis due to other sexually transmitted disease organisms, such as N. gonorrhoeae or herpes simplex virus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/41/24214?source=see_link&amp;anchor=H5#H5\">",
"     \"Urine sampling and culture in the diagnosis of urinary tract infection in adults\", section on 'Sterile pyuria'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688584\">",
"    <span class=\"h3\">",
"     Pelvic inflammatory disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. trachomatis can ascend to the upper reproductive tract, where pelvic inflammatory disease (PID) can result. In some studies of women presenting to sexually transmitted disease clinics, 2 to 4.5 percent developed clinical PID in the two weeks between diagnosis of chlamydia infection and follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. One small study of 20 women with N. gonorrhoeae and C. trachomatis coinfection who were given antibiotics that were ineffective against chlamydia found a 30 percent incidence of PID after seven weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/11\">",
"     11",
"    </a>",
"    ]. In contrast, studies of lower risk women have found no cases of clinical PID after a year of untreated chlamydial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/12\">",
"     12",
"    </a>",
"    ]. These studies likely underestimate the incidence of PID in chlamydial infection, as many cases of PID may cause no symptoms and only be suspected years later in the setting of tubal infertility [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When symptoms of PID are present, abdominal or pelvic pain are the most common, and their presence in the setting of cervicitis or a diagnosis of chlamydial infection should prompt strong suspicion for upper genital tract involvement. Signs of PID include cervical motion and uterine or adnexal tenderness. PID due to C. trachomatis is associated with higher rates of subsequent tubal infertility, ectopic pregnancy, and chronic pelvic pain when compared with PID caused by gonorrhea, which typically causes a more acute symptomatic presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The clinical manifestations, diagnosis, and treatment of PID are discussed in further detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"     \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35832?source=see_link\">",
"     \"Treatment of pelvic inflammatory disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688592\">",
"    <span class=\"h3\">",
"     Perihepatitis (Fitzhugh-Curtis syndrome)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally, patients with chlamydia infection develop perihepatitis, an inflammation of the liver capsule and adjacent peritoneal surfaces (",
"    <a class=\"graphic graphic_picture graphicRef50868 \" href=\"UTD.htm?23/17/23824\">",
"     picture 3",
"    </a>",
"    ). Perihepatitis is more commonly seen in the setting of actual PID, occurring in 5 to up to 15 percent of cases. It is associated with right-upper quadrant pain or pleuritic pain, but there are typically no liver enzyme abnormalities. The pathogenesis of this entity is not fully understood but may involve either direct extension of infected material from the cul-de-sac through the peritoneum",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lymphatics, or an immunologically mediated mechanism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical features and diagnosis of pelvic inflammatory disease\", section on 'Perihepatitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9967121\">",
"    <span class=\"h3\">",
"     Complications of pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beyond the risk of future ectopic pregnancy following chlamydia-associated PID, chlamydial genital infection during pregnancy can increase the risk for premature rupture of the membranes and preterm delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/16\">",
"     16",
"    </a>",
"    ]. Among 3913 pregnant Dutch women who were screened for C. trachomatis, the risk of delivery prior to 32 weeks gestation was higher in those with chlamydial infection than in those without (adjusted OR 4.35, 95% CI 1.3-15.2). Miscarriage and perinatal death were not associated with chlamydial infection. The risk of transmission to the newborn is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/21/27992?source=see_link&amp;anchor=H4#H4\">",
"     \"Chlamydia trachomatis infections in the newborn\", section on 'Risk of transmission'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688613\">",
"    <span class=\"h2\">",
"     Proctitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;While women can experience rectal infection with chlamydia, the responsible strains are the typical genital serovars (D through K), and they are typically asymptomatic and do not have long-term sequelae. This is in contrast to the proctitis caused by the LGV serovars (L1, L2, L3), which almost exclusively affect men who have sex with men. (See",
"    <a class=\"local\" href=\"#H22688649\">",
"     'Proctitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688620\">",
"    <span class=\"h1\">",
"     CLINICAL SYNDROMES IN MEN",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5188668\">",
"    <span class=\"h2\">",
"     Urogenital infection",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688628\">",
"    <span class=\"h3\">",
"     Urethritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chlamydia trachomatis is the most common cause of nongonococcal urethritis in men. The proportion of cases that are asymptomatic vary by population and range from 40 to 96 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/4,17,18\">",
"     4,17,18",
"    </a>",
"    ]. When men do have symptoms, they typically present with a mucoid or watery urethral discharge, and dysuria is often a prominent complaint. The discharge is often clear and only seen upon milking the urethra [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/19\">",
"     19",
"    </a>",
"    ]. Sometimes the discharge is so scant that men only notice stained undergarments in the morning [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/20\">",
"     20",
"    </a>",
"    ]. The Gram stain of urethral discharge generally shows more than five leukocytes per high powered field (",
"    <a class=\"graphic graphic_picture graphicRef56547 \" href=\"UTD.htm?37/63/38898\">",
"     picture 4",
"    </a>",
"    ), although this finding is not seen in up to a third of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/21\">",
"     21",
"    </a>",
"    ]. The incubation period is variable but is typically 5 to 10 days after exposure. This is in contrast to the more copious and purulent urethral discharge and shorter (two to seven days) incubation period for gonococcal urethritis. However, these syndromes frequently overlap and cannot reliably be distinguished on clinical grounds only.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688635\">",
"    <span class=\"h3\">",
"     Epididymitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. trachomatis is one of the most frequent pathogens in epididymitis among sexually active men &lt;35 years of age, along with Neisseria gonorrhoeae. Men with acute epididymitis typically have unilateral testicular pain and tenderness, hydrocele, and palpable swelling of the epididymis. Occasionally, C. trachomatis infection can be misdiagnosed as a testicular malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/22\">",
"     22",
"    </a>",
"    ]. Ultrasound findings include epididymal hyperemia and swelling, but a normal ultrasound does not rule out clinical epididymitis.",
"   </p>",
"   <p>",
"    Asymptomatic urethritis frequently accompanies sexually transmitted epididymitis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/23\">",
"     23",
"    </a>",
"    ]. In these cases, Gram stain of urethral secretions and urine microscopy can demonstrate polymorphonuclear leukocytes.",
"   </p>",
"   <p>",
"    The clinical presentation, diagnosis, and management of epididymitis are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44360?source=see_link&amp;anchor=H12#H12\">",
"     \"Evaluation of the acute scrotum in adults\", section on 'Epididymitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/39/32376?source=see_link&amp;anchor=H13#H13\">",
"     \"Causes of scrotal pain in children and adolescents\", section on 'Epididymitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688642\">",
"    <span class=\"h3\">",
"     Prostatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. trachomatis may be an etiology in some cases of chronic prostatitis, although this attribution remains highly speculative. Some studies have shown that men with chronic prostatitis without a clear bacterial etiology had detectable chlamydial antigen in urine or prostatic secretions more frequently than men with pelvic pain but no signs of prostatic inflammation (21 to 25 versus 0 to 6 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. Symptoms in these men included dysuria, urinary dysfunction, pain with ejaculation, and pelvic pain. By definition, their expressed prostatic secretions demonstrated an elevated number of leukocytes on microscopy. These findings are similar to those in chronic bacterial prostatitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/60/23496?source=see_link\">",
"     \"Chronic bacterial prostatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688649\">",
"    <span class=\"h2\">",
"     Proctitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chlamydial proctitis, defined as inflammation of the distal rectal mucosa, is relatively uncommon and occurs almost exclusively in men who have sex with men (MSM) who have had receptive anal intercourse [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/27\">",
"     27",
"    </a>",
"    ]. The clinical presentation of chlamydial proctitis depends on the infecting chlamydial serovars.",
"   </p>",
"   <p>",
"    The L1, L2 and L3 serovars of C. trachomatis cause the disease known as lymphogranuloma venereum (LGV), which can present as anorectal disease and has been reported in outbreaks among European and North American MSM, particularly those who are HIV-infected [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/28\">",
"     28",
"    </a>",
"    ]. Symptoms occur in the vast majority of cases. These include anorectal pain, discharge, tenesmus, rectal bleeding and constipation, with widely variant frequencies reported in case series [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/28\">",
"     28",
"    </a>",
"    ]. Systemic symptoms of fever and malaise are also often present. Anoscopic findings are nonspecific, but include mucosal friability, internal lesions, masses or polyps, and mucopurulent exudate. The presentation can be mistaken for inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Left untreated, rectal infection with the L1, L2, and L3 serovars can lead to rectal fistulae and strictures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/36/21063?source=see_link\">",
"     \"Lymphogranuloma venereum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The non-LGV serovars that cause genital infection (serovars D through K) can also cause infection of the rectum, particularly in MSM, but in contrast to LGV, these infections are usually asymptomatic. As an example, in a study that screened MSM for rectal chlamydial infection, only 49 of 301 cases (16 percent) of non-LGV infection were symptomatic compared with 58 of 62 cases (95 percent) of rectal LGV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/27\">",
"     27",
"    </a>",
"    ]. Routine annual screening of this site (or more frequently, in those at ongoing risk) is recommended for MSM, particularly in the HIV-infected person [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688657\">",
"    <span class=\"h2\">",
"     Reactive arthritis/reactive arthritis triad (RAT)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 1 percent of men with urethritis develop reactive arthritis, and approximately one-third of these patients have the complete reactive arthritis triad (RAT) formerly referred to as Reiter syndrome (arthritis, uveitis, and urethritis). C. trachomatis appears to be the most common inciting pathogen [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. The association between chlamydia and reactive arthritis has been further suggested by techniques that can detect chlamydial nucleic acids in synovial tissue. As an example, seven of nine patients with RAT had a positive in situ hybridization test for chlamydial RNA from samples of synovial tissue compared with 3 of 13 patients without RAT (the cause of the arthritis in these three patients was not otherwise defined) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/33\">",
"     33",
"    </a>",
"    ]. In another study, polymerase chain reaction testing detected chlamydial DNA on stored synovial tissue biopsies from five of eight patients with sexually-acquired reactive arthritis and one control patient with another form of arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations and treatment of reactive arthritis are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=see_link\">",
"     \"Reactive arthritis (formerly Reiter syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5188425\">",
"    <span class=\"h1\">",
"     CLINICAL SYNDROMES COMMON TO WOMEN AND MEN",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5188452\">",
"    <span class=\"h2\">",
"     Conjunctivitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The C. trachomatis serovars that cause genital disease (D through K) can infect the epithelial cells of the conjunctiva. This typically occurs through direct inoculation with infected genital secretions. Sexually acquired chlamydial conjunctivitis typically presents as a non-purulent erythematous injection of the epithelial surface (inclusion conjunctivitis), which may take on a cobbled appearance (",
"    <a class=\"graphic graphic_picture graphicRef84033 \" href=\"UTD.htm?14/55/15223\">",
"     picture 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/17/20760?source=see_link&amp;anchor=H12#H12\">",
"     \"Conjunctivitis\", section on 'Adult inclusion conjunctivitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This type of ocular infection is distinct from endemic trachoma, which is caused by serovars A through C. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8409?source=see_link&amp;anchor=H5#H5\">",
"     \"Epidemiology, diagnosis, and management of trachoma\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5188491\">",
"    <span class=\"h2\">",
"     Pharyngitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. trachomatis is not thought to be an important cause of pharyngitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9966941\">",
"    <span class=\"h2\">",
"     Genital lymphogranuloma venereum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphogranuloma venereum is primarily endemic in heterosexuals in areas of East and West Africa, India, parts of Southeast Asia, and the Caribbean and has been recognized as a sexually transmitted infection among travelers returning those areas. In contrast to the anorectal disease in MSM discussed above, these cases generally run a benign course with finding of a non-painful, small, stellate genital ulcer followed by development of inguinal lymphadenopathy (buboes). The clinical manifestations of genital LGV are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/36/21063?source=see_link\">",
"     \"Lymphogranuloma venereum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688671\">",
"    <span class=\"h1\">",
"     DIAGNOSIS OF CHLAMYDIAL INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic test of choice for chlamydial infection of the genitourinary tract is nucleic acid amplification testing (NAAT) of vaginal swabs for women or first-catch urine for men, although NAAT can also be performed on endocervical and urethral swab specimens. If NAAT methods are unavailable, antigen detection and genetic probe methods can be applied to endocervical or urethral swabs to diagnose chlamydia. In resource-limited settings, rapid tests for chlamydia may be used for diagnosis, if available. When no specific diagnostic tests are available, the presumptive diagnosis of chlamydia is made when symptoms and signs of the clinical syndromes associated with chlamydia are present in young or sexually active patients.",
"   </p>",
"   <p>",
"    Rectal chlamydial infection in persons who engage in receptive anal intercourse can be diagnosed by testing a rectal swab specimen. Some laboratories have met testing validation requirements for NAAT testing of rectal specimens under the Clinical Laboratory Improvement Amendment (CLIA) regulations. If NAAT testing of rectal specimens is not available, serology can support the diagnosis of chlamydial proctitis but has limitations. Clinicians who suspect LGV proctitis should seek expert advice from local public health authorities and infectious disease specialists on how to diagnose the condition effectively. Often, this is not possible and empiric therapy is warranted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=see_link&amp;anchor=H23#H23\">",
"     \"Treatment of Chlamydia trachomatis infection\", section on 'Proctitis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    NAAT can be performed on conjunctival swabs to diagnose chlamydial conjunctivitis. Chlamydial pharyngeal infection is thought to be uncommon and generally not a target for diagnostic testing.",
"   </p>",
"   <p>",
"    If non-NAAT-based testing is used for diagnosis or if adequate follow-up cannot be insured, patients with signs and symptoms consistent with chlamydia should be treated empirically before diagnostic test results return. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=see_link&amp;anchor=H5622636#H5622636\">",
"     \"Treatment of Chlamydia trachomatis infection\", section on 'Indications for empiric therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5188506\">",
"    <span class=\"h2\">",
"     Diagnostic techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic techniques include NAAT, culture, antigen detection, and genetic probes; microscopy is not useful for the diagnosis of chlamydia. Because of superior sensitivity and specificity, NAAT is the diagnostic technique of choice, where available. With this technique, noninvasive screening options, such as first-catch urine testing or self-collected vaginal swabs, are possible and have become the diagnostic approach of choice for chlamydial (and gonococcal) infections. However, for women presenting with symptomatic cervicitis who undergo a speculum exam, or for high-risk women undergoing routine Pap smear, NAAT can be performed on either endocervical or vaginal swabs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688685\">",
"    <span class=\"h3\">",
"     Nucleic acid amplification",
"    </span>",
"    &nbsp;&mdash;&nbsp;NAAT methodology consists of amplifying C. trachomatis DNA or RNA sequences using polymerase chain reaction (PCR), transcription-mediated amplification (TMA), or strand displacement amplification (SDA). These sensitive and specific tests have become the \"gold standard\", and are the preferred diagnostic method, if available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5188925\">",
"    <span class=\"h4\">",
"     Test performance by specimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;A major advantage of NAATs is their excellent performance on specimens that do not require a pelvic examination or the necessity to obtain a urethral swab. These tests can be applied to urine or vaginal swabs in addition to endocervical and urethral swabs [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/35\">",
"     35",
"    </a>",
"    ]. In fact, in women, a swab of vaginal fluid is the preferred approach for diagnosing chlamydial infection, as this specimen provides the highest sensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/36\">",
"     36",
"    </a>",
"    ]. First-catch urine submitted for NAAT should be collected from the initial stream (approximately the first 10 mL) without pre-cleansing of the genital areas. Ideally, the patient should not have voided in the two hours prior to specimen collection. The performance of these is not affected by the presence of purulent material or blood [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review pooled data from 29 studies to assess the sensitivity and specificity of NAAT for C. trachomatis infection in urine specimens [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/38\">",
"     38",
"    </a>",
"    ]. Summary estimates for sensitivity and specificity were calculated for urine and cervical sampling for three NAAT methods (PCR, TMA, or SDA). The analysis demonstrated that the sensitivity and specificity of non-invasive testing (urine) was comparable to invasive testing, although more data was available for analysis on PCR testing than the other two methods as illustrated below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For the 14 studies of the PCR assay, the pooled sensitivity and specificity were 83 and 99.5 percent for urine samples and 86 and 99.6 percent for cervical samples.",
"     </li>",
"     <li>",
"      For the four studies of the TMA assay, the pooled sensitivity and specificity were 93 and 99 percent for urine samples and 97 and 99 percent for cervical samples.",
"     </li>",
"     <li>",
"      For the two studies of the SDA assay, the pooled sensitivity and specificity were 80 and 99 percent for urine samples and 94 and 98 percent for cervical samples.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Subsequent to this meta-analysis, several studies confirmed that in women, NAAT on vaginal swab fluid, collected either by the clinician or the patient, had even higher sensitivity than urine and, in some cases, than endocervical swab [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several studies have shown that NAAT on rectal specimens is more sensitive than culture in detecting rectal chlamydia and still has high specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/35,39\">",
"     35,39",
"    </a>",
"    ]. Self-collection of these samples can also provide another option to facilitate screening in MSM [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/40\">",
"     40",
"    </a>",
"    ]. Some laboratories in the United States have met testing validation requirements under the Clinical Laboratory Improvement Amendment (CLIA) regulations and will thus perform NAAT on rectal specimens, but validated rectal NAAT is not uniformly available. Information about the process to obtain this validation in the United States can be found at",
"    <span class=\"nowrap\">",
"     www.cdc.gov/std.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688706\">",
"    <span class=\"h3\">",
"     Rapid tests for chlamydia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although NAAT has replaced culture as the new \"gold standard\", same-day results are not available. Furthermore, NAAT is currently too expensive for use in resource-limited settings. Several immunoassay-based tests are being developed, which are based on monoclonal antibody binding of chlamydial antigens from self-collected samples. These rapid tests provide results within 30 minutes of testing and are less expensive to perform and simple to interpret since testing results are reflected in a test strip color change [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A promising test was reported in 2009 and involves the use of the Chlamydia Rapid Test (CRT) on first-void urine in men. This assay, based on use of a monoclonal antibody to chlamydia lipopolysaccharide, was compared to NAAT (PCR) as a gold standard. The sensitivity, specificity, positive predictive value, and negative predictive value of the CRT was 83 percent",
"    <span class=\"nowrap\">",
"     (90/109),",
"    </span>",
"    99 percent",
"    <span class=\"nowrap\">",
"     (1085/1102),",
"    </span>",
"    84 percent",
"    <span class=\"nowrap\">",
"     (90/107),",
"    </span>",
"    and 98 percent",
"    <span class=\"nowrap\">",
"     (1085/1104),",
"    </span>",
"    respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/42\">",
"     42",
"    </a>",
"    ]. This test is not commercially available in the U.S.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5189076\">",
"    <span class=\"h3\">",
"     Culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Culture methods are now limited to research and reference laboratories due to the expense and technical expertise required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5189044\">",
"    <span class=\"h3\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;C. trachomatis serology (complement fixation titers &gt;1:64) can support the diagnosis of chlamydia in the appropriate clinical context but is performed infrequently, not standardized, and requires a high level of expertise to interpret. It may also not perform as well in diagnosing rectal infections in men as it does upper genital tract infection in women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5189058\">",
"    <span class=\"h3\">",
"     Antigen detection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antigen detection requires invasive testing using a swab from the cervix or urethra. The sensitivity of this method is 80 to 95 percent compared with culture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5189065\">",
"    <span class=\"h3\">",
"     Genetic probe methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because they do not involve amplification of genetic targets, available genetic probe methods require invasive testing using a direct swab from the cervix or urethra. The sensitivity of this assay is approximately 80 percent compared with culture. The main advantage of these tests is their low cost; however, because their sensitivity is considerably lower than NAAT and because NAAT have become more cost-competitive, these tests are not used as frequently as in the past.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5189092\">",
"    <span class=\"h2\">",
"     Whom to test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any sexually active individual with signs and symptoms consistent with the clinical syndromes associated with chlamydia should undergo diagnostic testing for C. trachomatis. However, because the majority of chlamydial infections are asymptomatic, routine screening with NAAT should be offered to sexually active patients at high risk of infection and complications of chlamydia. This includes women who are 25 years old or younger, pregnant, or have new or many sexual partners, and men who had sex with men. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8408?source=see_link\">",
"     \"Screening for Chlamydia trachomatis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Furthermore, any patients with documented gonococcal infection should also undergo testing for chlamydia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4057931\">",
"    <span class=\"h3\">",
"     Patients with recent exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients who present within one to two weeks of a potential or known exposure to chlamydia (eg, sexual assault), diagnostic testing should not be used to inform the decision to treat. Such patients should be treated empirically. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=see_link&amp;anchor=H43#H43\">",
"     \"Treatment of Chlamydia trachomatis infection\", section on 'Management of sex partners'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688713\">",
"    <span class=\"h3\">",
"     Patients with persistent symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent symptoms in patients with confirmed chlamydial infection after appropriate therapy with good adherence are usually not due to primary treatment failure. In a longitudinal cohort of adolescent women assessed every three months, NAAT testing and ompA genotyping were used to characterize rates of reinfection or persistent infection using molecular description [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/43\">",
"     43",
"    </a>",
"    ]. The investigators observed 478 episodes of infection in 210 participants. Of these women, 121 had repeat infections. Most of these (84 percent) were likely reinfections, 14 percent were classified as probable or possible treatment failures, and only 2.2 percent were infections that persisted in the absence of documented treatment.",
"   </p>",
"   <p>",
"    Thus, persistent symptoms related to chlamydial infection are usually due to recurrent infections. Clinicians should inquire about possible reinfection, including whether sex partners were treated. Nucleic acid amplification testing (NAAT) remains the test of choice to evaluate for reinfection in the setting of persistent symptoms regardless of interval since the prior treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688720\">",
"    <span class=\"h3\">",
"     Recurrence of symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrence of symptoms after initial resolution should lead to a repeat evaluation for chlamydia and other sexually transmitted diseases that cause urethritis or cervicitis, including gonorrhea, bacterial vaginosis, and other pathogens. Nucleic acid amplification testing (NAAT) remains the test of choice to evaluate for reinfection in the setting of symptom recurrence regardless of interval since the prior treatment. A repeat diagnosis of chlamydia in a previously treated patient usually indicates reinfection, as noted above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4057088\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4057143\">",
"    <span class=\"h2\">",
"     Urogenital infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other sexually transmitted pathogens, including Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium, can cause infections similar to C. trachomatis. The differential diagnosis of urogenital chlamydial infections depends on the particular clinical syndrome and is discussed in the separate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/4/64?source=see_link&amp;anchor=H2#H2\">",
"     \"Acute cervicitis\", section on 'Etiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical features and diagnosis of pelvic inflammatory disease\", section on 'Differential diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/43/19126?source=see_link\">",
"     \"Infectious causes of dysuria in adult men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4057157\">",
"    <span class=\"h2\">",
"     Proctitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of infectious proctitis in men who have sex with men (MSM) also includes N. gonorrhoeae, herpes simplex virus, and Treponema pallidum infections [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/44\">",
"     44",
"    </a>",
"    ]. The frequency of these causes was evaluated in a review of 101 episodes of proctitis among MSM in San Francisco; anoscopy was performed and specimens obtained that were tested for the above organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10729/abstract/44\">",
"     44",
"    </a>",
"    ]. The following frequency of causes was noted:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      None &ndash; 45 percent",
"     </li>",
"     <li>",
"      Gonorrhea only &ndash; 20 percent",
"     </li>",
"     <li>",
"      Herpes simplex only &ndash; 13 percent",
"     </li>",
"     <li>",
"      Chlamydia only &ndash; 11 percent",
"     </li>",
"     <li>",
"      Mixed infections &ndash; 10 percent, including 8 percent with chlamydia",
"     </li>",
"     <li>",
"      Syphilis only &ndash; 1 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4057150\">",
"    <span class=\"h2\">",
"     Coinfection with N. gonorrhoeae",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to note that Neisseria gonorrhoeae not only causes similar clinical syndromes as C. trachomatis but also coexists in a significant proportion of patients with chlamydial infection. Thus, any testing for C. trachomatis should also prompt testing for N. gonorrhoeae. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=see_link&amp;anchor=H60698042#H60698042\">",
"     \"Treatment of Chlamydia trachomatis infection\", section on 'Coinfection with gonorrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22688734\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In women, Chlamydia trachomatis most commonly affects the cervix. The majority of infected women are asymptomatic, although some may present with the typical findings of cervicitis, including vaginal discharge, abnormal vaginal bleeding, and purulent endocervical discharge on exam. (See",
"      <a class=\"local\" href=\"#H22688570\">",
"       'Cervicitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most concerning complication of untreated cervical chlamydial infection is pelvic inflammatory disease, which in turn can lead to infertility, ectopic pregnancy, or chronic pelvic pain. (See",
"      <a class=\"local\" href=\"#H22688584\">",
"       'Pelvic inflammatory disease'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In men, Chlamydia trachomatis is the most common cause of nongonococcal urethritis. The majority of infected men are asymptomatic. When present, symptoms include a mucoid or watery urethral discharge and dysuria. Chlamydia trachomatis is a frequent cause of acute epididymitis in men younger than 35 years old and may be an etiology in some cases of chronic prostatitis. (See",
"      <a class=\"local\" href=\"#H5188668\">",
"       'Urogenital infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The serovars of Chlamydia trachomatis that cause lymphogranuloma venereum have been increasingly reported in cases of proctitis in men who have sex with men. These cases tend to be symptomatic, with anorectal pain, discharge, and tenesmus, and can be mistaken for inflammatory bowel disease. (See",
"      <a class=\"local\" href=\"#H22688649\">",
"       'Proctitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnostic test of choice for chlamydial infection of the genitourinary tract is nucleic acid amplification testing (NAAT) of vaginal swabs for women or urine for men. Many laboratories have also validated NAAT on rectal swabs to diagnose chlamydial proctitis. If non-NAAT-based testing is used for diagnosis or if adequate follow-up cannot be insured, patients with signs and symptoms consistent with chlamydia should be treated empirically before diagnostic test results return. (See",
"      <a class=\"local\" href=\"#H22688671\">",
"       'Diagnosis of chlamydial infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Any sexually active individual with signs and symptoms consistent with the clinical syndromes associated with chlamydia and patients with documented gonococcal infection should undergo diagnostic testing for Chlamydia trachomatis. Because the majority of chlamydial infections are asymptomatic, routine screening with NAAT should be offered to sexually active patients at high risk of infection and complications of chlamydia. (See",
"      <a class=\"local\" href=\"#H5189092\">",
"       'Whom to test'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8408?source=see_link\">",
"       \"Screening for Chlamydia trachomatis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neisseria gonorrhoeae not only causes similar clinical syndromes as C. trachomatis but also coexists in a significant proportion of patients with chlamydial infection. Thus, any testing for C. trachomatis should also prompt testing for N. gonorrhoeae. (See",
"      <a class=\"local\" href=\"#H4057088\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2010. CDC; Department of Health and Human Services, Atlanta, GA 2011.",
"    </li>",
"    <li>",
"     Stamm WE. Chlamydia trachomatis infections of the adult. In: Sexually Transmitted Diseases, 4th Ed, Holmes KK, Sparling PF, Mardh PA, et al (Eds), McGraw-Hill, New York 2008. p.575.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/3\">",
"      Samoff E, Koumans EH, Markowitz LE, et al. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 2005; 162:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/4\">",
"      Detels R, Green AM, Klausner JD, et al. The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis 2011; 38:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/5\">",
"      Marrazzo JM. Mucopurulent cervicitis: no longer ignored, but still misunderstood. Infect Dis Clin North Am 2005; 19:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/6\">",
"      Gaydos CA, Howell MR, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998; 339:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/7\">",
"      Geisler WM. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis 2010; 201 Suppl 2:S104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/8\">",
"      Geisler WM, Wang C, Morrison SG, et al. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008; 35:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/9\">",
"      Bachmann LH, Richey CM, Waites K, et al. Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center. Sex Transm Dis 1999; 26:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/10\">",
"      Hook EW 3rd, Spitters C, Reichart CA, et al. Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA 1994; 272:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/11\">",
"      Stamm WE, Guinan ME, Johnson C, et al. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984; 310:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/12\">",
"      Morr&eacute; SA, van den Brule AJ, Rozendaal L, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002; 13 Suppl 2:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/13\">",
"      Sweet RL. Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management. Curr Infect Dis Rep 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/14\">",
"      Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. World Health Organization Task Force on the Prevention and Management of Infertility. Sex Transm Dis 1995; 22:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/15\">",
"      Svensson L, Westr&ouml;m L, Ripa KT, M&aring;rdh PA. Differences in some clinical and laboratory parameters in acute salpingitis related to culture and serologic findings. Am J Obstet Gynecol 1980; 138:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/16\">",
"      Rours GI, Duijts L, Moll HA, et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. Eur J Epidemiol 2011; 26:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/17\">",
"      Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005; 41:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/18\">",
"      Cecil JA, Howell MR, Tawes JJ, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis 2001; 184:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/19\">",
"      Takahashi S, Takeyama K, Kunishima Y, et al. Analysis of clinical manifestations of male patients with urethritis. J Infect Chemother 2006; 12:283.",
"     </a>",
"    </li>",
"    <li>",
"     Stamm WE, Jones RB, and Batteiger BE. Chlamydia trachomatis (trachoma, perinatal infections, lymphogranuloma venereum, and other genital infections. In: Principles and Practice of Infectious Disease, 6th edition, Mandell GL, Bennett JE, and Dolin R.  (Eds), Elsevier, 2005. Vol 2, p.2239-2255.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/21\">",
"      Bradshaw CS, Tabrizi SN, Read TR, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006; 193:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/22\">",
"      Ward AM, Rogers JH, Estcourt CS. Chlamydia trachomatis infection mimicking testicular malignancy in a young man. Sex Transm Infect 1999; 75:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/23\">",
"      Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/24\">",
"      Mutlu N, Mutlu B, Culha M, et al. The role of Chlamydia trachomatis in patients with non-bacterial prostatitis. Int J Clin Pract 1998; 52:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/25\">",
"      Ostaszewska I, Zdrodowska-Stefanow B, Badyda J, et al. Chlamydia trachomatis: probable cause of prostatitis. Int J STD AIDS 1998; 9:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/26\">",
"      G&uuml;m&uuml;�� B, Sengil AZ, Solak M, et al. Evaluation of non-invasive clinical samples in chronic chlamydial prostatitis by using in situ hybridization. Scand J Urol Nephrol 1997; 31:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/27\">",
"      Ward H, Alexander S, Carder C, et al. The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study. Sex Transm Infect 2009; 85:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/28\">",
"      Martin-Iguacel R, Llibre JM, Nielsen H, et al. Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries. Eur J Clin Microbiol Infect Dis 2010; 29:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/29\">",
"      Ahdoot A, Kotler DP, Suh JS, et al. Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York City. J Clin Gastroenterol 2006; 40:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/30\">",
"      H&oslash;ie S, Knudsen LS, Gerstoft J. Lymphogranuloma venereum proctitis: a differential diagnose to inflammatory bowel disease. Scand J Gastroenterol 2011; 46:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/31\">",
"      Kobayashi S, Kida I. Reactive arthritis: recent advances and clinical manifestations. Intern Med 2005; 44:408.",
"     </a>",
"    </li>",
"    <li>",
"     Rice P, Handsfield HH. Arthritis associated with sexually transmitted diseases. In: Sexually Transmitted Diseases, 4th Ed, Holmes KK, Sparling PF, Mardh PA, et al (Eds), McGraw-Hill, New York 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/33\">",
"      Rahman MU, Hudson AP, Schumacher HR Jr. Chlamydia and Reiter's syndrome (reactive arthritis). Rheum Dis Clin North Am 1992; 18:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/34\">",
"      Taylor-Robinson D, Gilroy CB, Thomas BJ, Keat AC. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 1992; 340:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/35\">",
"      Geisler WM. Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 2011; 53 Suppl 3:S92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/36\">",
"      Hobbs MM, van der Pol B, Totten P, et al. From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis 2008; 35:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/37\">",
"      Marrazzo JM, Johnson RE, Green TA, et al. Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections. J Clin Microbiol 2005; 43:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/38\">",
"      Cook RL, Hutchison SL, &Oslash;stergaard L, et al. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/39\">",
"      Cosentino LA, Campbell T, Jett A, et al. Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections. J Clin Microbiol 2012; 50:2005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/40\">",
"      Moncada J, Schachter J, Liska S, et al. Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests. J Clin Microbiol 2009; 47:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/41\">",
"      Greer L, Wendel GD Jr. Rapid diagnostic methods in sexually transmitted infections. Infect Dis Clin North Am 2008; 22:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/42\">",
"      Nadala EC, Goh BT, Magbanua JP, et al. Performance evaluation of a new rapid urine test for chlamydia in men: prospective cohort study. BMJ 2009; 339:b2655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/43\">",
"      Batteiger BE, Tu W, Ofner S, et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis 2010; 201:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10729/abstract/44\">",
"      Klausner JD, Kohn R, Kent C. Etiology of clinical proctitis among men who have sex with men. Clin Infect Dis 2004; 38:300.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 83019 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-93.125.6.160-7DBF348CA4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10729=[""].join("\n");
var outline_f10_30_10729=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22688734\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22688556\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22688563\">",
"      CLINICAL SYNDROMES IN WOMEN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9967428\">",
"      Genital infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22688570\">",
"      - Cervicitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9967056\">",
"      - Dysuria-pyuria syndrome due to urethritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22688584\">",
"      - Pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22688592\">",
"      - Perihepatitis (Fitzhugh-Curtis syndrome)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9967121\">",
"      - Complications of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22688613\">",
"      Proctitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22688620\">",
"      CLINICAL SYNDROMES IN MEN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5188668\">",
"      Urogenital infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22688628\">",
"      - Urethritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22688635\">",
"      - Epididymitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22688642\">",
"      - Prostatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22688649\">",
"      Proctitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22688657\">",
"      Reactive arthritis/reactive arthritis triad (RAT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5188425\">",
"      CLINICAL SYNDROMES COMMON TO WOMEN AND MEN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5188452\">",
"      Conjunctivitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5188491\">",
"      Pharyngitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9966941\">",
"      Genital lymphogranuloma venereum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22688671\">",
"      DIAGNOSIS OF CHLAMYDIAL INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5188506\">",
"      Diagnostic techniques",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22688685\">",
"      - Nucleic acid amplification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5188925\">",
"      Test performance by specimen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22688706\">",
"      - Rapid tests for chlamydia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5189076\">",
"      - Culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5189044\">",
"      - Serology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5189058\">",
"      - Antigen detection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5189065\">",
"      - Genetic probe methods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5189092\">",
"      Whom to test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4057931\">",
"      - Patients with recent exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22688713\">",
"      - Patients with persistent symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22688720\">",
"      - Recurrence of symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4057088\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4057143\">",
"      Urogenital infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4057157\">",
"      Proctitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4057150\">",
"      Coinfection with N. gonorrhoeae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22688734\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/83019\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/83019|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/17/36114\" title=\"picture 1\">",
"      Chlamydia cervicitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/13/22738\" title=\"picture 2\">",
"      Edematous ectopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/17/23824\" title=\"picture 3\">",
"      Perihepatitis in Chlamydia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/63/38898\" title=\"picture 4\">",
"      Chlamydia urethral Gram stain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/55/15223\" title=\"picture 5\">",
"      Chlamydia conjunctivitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/4/64?source=related_link\">",
"      Acute cervicitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/39/32376?source=related_link\">",
"      Causes of scrotal pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/21/27992?source=related_link\">",
"      Chlamydia trachomatis infections in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/60/23496?source=related_link\">",
"      Chronic bacterial prostatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/17/20760?source=related_link\">",
"      Conjunctivitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8409?source=related_link\">",
"      Epidemiology, diagnosis, and management of trachoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44360?source=related_link\">",
"      Evaluation of the acute scrotum in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/43/19126?source=related_link\">",
"      Infectious causes of dysuria in adult men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/36/21063?source=related_link\">",
"      Lymphogranuloma venereum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=related_link\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/13/8408?source=related_link\">",
"      Screening for Chlamydia trachomatis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34505?source=related_link\">",
"      Treatment of Chlamydia trachomatis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35832?source=related_link\">",
"      Treatment of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/41/24214?source=related_link\">",
"      Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_30_10730="Spontaneous cerebral and cervical artery dissection: Clinical features and diagnosis";
var content_f10_30_10730=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Spontaneous cerebral and cervical artery dissection: Clinical features and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10730/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10730/contributors\">",
"     David S Liebeskind, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10730/contributors\">",
"     Jeffrey Saver, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10730/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10730/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?10/30/10730/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?10/30/10730/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?10/30/10730/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H95541708\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial dissections are a common cause of stroke in the young, but may occur at any age. Dissection occurs when structural integrity of the arterial wall is compromised, allowing blood to collect between layers as an intramural hematoma.",
"   </p>",
"   <p>",
"    This topic will review the pathophysiology, etiology, clinical features, and diagnosis of spontaneous cerebral and cervical artery dissection. The treatment and prognosis of cervicocephalic dissection is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/28/21960?source=see_link\">",
"     \"Spontaneous cerebral and cervical artery dissection: Treatment and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other mechanisms of ischemic stroke and subarachnoid hemorrhage are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23513?source=see_link\">",
"     \"Ischemic stroke in children and young adults: Etiology and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9208?source=see_link\">",
"     \"Etiology and classification of stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/50/38696?source=see_link\">",
"     \"Nonaneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H163601625\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Separation of the arterial wall layers results in dissection. A false lumen arises in the space where blood seeps into the vessel wall (",
"    <a class=\"graphic graphic_figure graphicRef57866 \" href=\"UTD.htm?17/18/17698\">",
"     figure 1",
"    </a>",
"    ). Hemorrhage may be due to an intimal tear or result from rupture or other pathology in the vasa vasorum [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Subintimal dissections cause luminal stenosis or occlusion whereas subadventitial dissections largely result in dissecting aneurysm formation (",
"    <a class=\"graphic graphic_figure graphicRef57174 \" href=\"UTD.htm?24/48/25349\">",
"     figure 2",
"    </a>",
"    ). False lumen extension back into the true lumen can form a double channel for blood flow in the artery.",
"   </p>",
"   <p>",
"    Neurologic sequelae of extracranial and intracranial dissection may result from cerebral ischemia due to thromboembolism, hypoperfusion, or a combination of both. However, thromboembolism rather than hypoperfusion is considered the major cause of ischemic symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In addition, dissection and aneurysmal dilatation may cause local symptoms from compression of adjacent nerves and their feeding vessels, resulting in pain, partial oculosympathetic paresis (Horner syndrome), lower cranial neuropathies [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/5\">",
"     5",
"    </a>",
"    ], or cervical nerve root involvement. Pain is caused by activation of nociceptors from distension of the vessel wall due to the hematoma.",
"   </p>",
"   <p>",
"    In a minority of cases, dissection of intracranial arteries, which lack an external elastic lamina and have only a thin adventitial layer, can lead to vessel rupture with subarachnoid hemorrhage.",
"   </p>",
"   <p>",
"    Extracranial dissection is far more frequent than intracranial dissection in reports from North America and Europe. However, a study from South Korea suggests that intracranial dissection may be more common in Asian populations [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/6\">",
"     6",
"    </a>",
"    ]. Extracranial internal carotid dissection typically occurs 2 cm or more distal to the carotid bifurcation, near the skull base. Intracranial carotid dissection is most frequent in the supraclinoid segment [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/7\">",
"     7",
"    </a>",
"    ]. Vertebral artery dissection most commonly affects the V3 or V1 segments at the C1 to C2 level.",
"   </p>",
"   <p>",
"    Multiple simultaneous cervicocephalic dissections are found in 13 to 22 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/8-11\">",
"     8-11",
"    </a>",
"    ], and may occur more often in women than men [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/9,10,12\">",
"     9,10,12",
"    </a>",
"    ]. Three or more dissections occur in approximately 2 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/12\">",
"     12",
"    </a>",
"    ]. Although evidence is limited to small patient numbers, multiple simultaneous dissections are not typically associated with a known underlying predisposition to dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/12\">",
"     12",
"    </a>",
"    ]. Rather, most cases may be due to a transient vasculopathy following minor trauma or infection, with ischemia manifest in only one of the downstream arterial territories.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H163601652\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Histopathologic specimens of dissected arteries are rarely obtained, yet examination may reveal intramural hemorrhage, disruption of the subintimal plane and less frequent separation of the media and adventitia (",
"    <a class=\"graphic graphic_picture graphicRef73102 \" href=\"UTD.htm?5/37/5720\">",
"     picture 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/13\">",
"     13",
"    </a>",
"    ]. In a case-control study, superficial temporal artery specimens obtained by biopsy or autopsy from 14 patients with spontaneous cervical artery dissection showed pathologic changes involving mainly the adventitial and medial layers, with vacuolar degeneration and fissuring along with capillary neoangiogenesis and microscopic erythrocyte extravasation into connective tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/2\">",
"     2",
"    </a>",
"    ]. In contrast, only one of nine control arteries obtained from accident victims showed pathologic changes in the outer arterial walls.",
"   </p>",
"   <p>",
"    There is a high prevalence of ultrastructural connective tissue abnormalities in patients with apparently sporadic cervicocephalic artery dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. These abnormalities consist primarily of composite fibrils within collagen bundles and fragmented elastic fibers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95541729\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, dissection occurs when the structural integrity of the arterial wall is compromised, allowing blood to collect between layers as an intramural hematoma. Common causes include various degrees of trauma or spontaneous events, with underlying predispositions in some cases. Intrinsic factors related to vessel wall integrity and extrinsic factors, including minor trauma, both contribute to dissection formation. Dissection can also result from major head and neck trauma, but most dissections occur spontaneously or after minor or trivial injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H163601532\">",
"    <span class=\"h2\">",
"     Minor trauma and other triggers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical activities associated with dissection include skating [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/17\">",
"     17",
"    </a>",
"    ], tennis [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/18,19\">",
"     18,19",
"    </a>",
"    ], basketball [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/20\">",
"     20",
"    </a>",
"    ], volleyball [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/21\">",
"     21",
"    </a>",
"    ], swimming [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/22\">",
"     22",
"    </a>",
"    ], scuba diving [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/23-28\">",
"     23-28",
"    </a>",
"    ], dancing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/29,30\">",
"     29,30",
"    </a>",
"    ], yoga [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/31\">",
"     31",
"    </a>",
"    ], vigorous exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/31\">",
"     31",
"    </a>",
"    ], trampoline use [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/32\">",
"     32",
"    </a>",
"    ], roller coaster or amusement park rides [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/33-38\">",
"     33-38",
"    </a>",
"    ], and minor sports injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. Other reported precipitating activities include childbirth [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/41\">",
"     41",
"    </a>",
"    ], sexual intercourse [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/42\">",
"     42",
"    </a>",
"    ], and coughing or sneezing [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/31\">",
"     31",
"    </a>",
"    ]. Chiropractic neck manipulation may trigger dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/43-47\">",
"     43-47",
"    </a>",
"    ], but the absolute incidence of dissection caused by spinal manipulation is unknown [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H163601524\">",
"    <span class=\"h2\">",
"     Predisposing conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although definitive evidence is mostly lacking, various connective tissue and vascular disorders have been associated with dissection, including the following [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/15,49,50\">",
"     15,49,50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ehlers&ndash;Danlos syndrome type IV (vascular Ehlers-Danlos)",
"     </li>",
"     <li>",
"      Fibromuscular dysplasia [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/51,52\">",
"       51,52",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Marfan syndrome",
"     </li>",
"     <li>",
"      Osteogenesis imperfecta [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/53\">",
"       53",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Cystic medial necrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/54\">",
"       54",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Reticular fiber deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/55\">",
"       55",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Homocystinuria [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/56\">",
"       56",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Autosomal dominant polycystic kidney disease [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/57\">",
"       57",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Alpha-1 antitrypsin deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/58\">",
"       58",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Segmental mediolytic arteriopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/59\">",
"       59",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, the proportion of patients with spontaneous dissection who are affected by a known connective tissue or vascular disorder is low [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. The most common association is with fibromuscular dysplasia, a nonspecific arteriopathy, which accounts for up to 15 percent of all cases of cervicocephalic dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/62\">",
"     62",
"    </a>",
"    ]. Ehlers-Danlos syndrome type IV is found in &lt;2 percent of all cases of cervical or cerebral artery dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. The prevalence of dissection among all patients with Ehlers-Danlos is similarly infrequent. In one cohort of over 400 patients with Ehlers Danlos type IV, carotid artery dissection was observed in 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For the remaining connective tissue and vascular disorders listed above, all of which are rare diseases, it remains uncertain whether the association with dissection is greater than would be expected by chance alone [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/50\">",
"     50",
"    </a>",
"    ]. Marfan syndrome is a known cause of aortic dissection, but only a few cases of isolated cervicocephalic dissection have been reported in patients with Marfan syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/64,65\">",
"     64,65",
"    </a>",
"    ], and several large series of patients with Marfan syndrome have reported no occurrences of cervicocephalic dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/66,67\">",
"     66,67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although supporting evidence is weak, a host of other conditions have been associated with cervicocephalic dissection, include recent infection, hypertension, migraine, longer styloid process length, aortic root diameter &gt;34 mm, oral contraceptive use, smoking, elevated homocysteine levels, alcohol use, redundancy of vessels, higher body height, and lower body weight [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/50,68-79\">",
"     50,68-79",
"    </a>",
"    ]. Dissections have been noted in association with other vascular findings such as cerebral aneurysms and arterial fenestrations [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H80087852\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the monogenic connective tissue diseases discussed above, polygenetic factors may be involved in the etiology and pathophysiology of dissection as part a multifactorial predisposition [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/60\">",
"     60",
"    </a>",
"    ]. In theory, such factors could cause an inherited weakness of the vessel wall, thereby increasing susceptibility to dissection from minor trauma, inflammation, thrombosis or other environmental triggers.",
"   </p>",
"   <p>",
"    However, there are no established genetic markers for cervicocephalic dissection. A systematic review published in 2009 noted that the majority of genetic studies in this field were negative, and were also markedly underpowered [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/60\">",
"     60",
"    </a>",
"    ]. The following additional observations were made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autosomal dominant Ehlers-Danlos syndrome type IV caused by a mutation in the COL3A1 gene probably accounts for &lt;2 percent of all cervical artery dissection cases.",
"     </li>",
"     <li>",
"      With Marfan syndrome, an autosomal dominant condition caused by a mutation in the fibrillin 1 gene, spontaneous cervical artery dissection appears to be exceptional, and should be distinguished from aortic dissection that extends in the brachiocephalic arteries.",
"     </li>",
"     <li>",
"      Among 15 genetic association studies, 10 were negative while 5 reported associations with three genetic variants in three different candidate genes (ICAM-1, COL3A1 and MTHFR C677T genotype). A meta-analysis of these reports found a significant association only for the MTHFR C677T genotype (odds ratio 1.67, 95% CI 1.21-2.31).",
"     </li>",
"     <li>",
"      Among nine genetic screening studies and four linkage studies, most results were negative.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the paucity of evidence, there are valid reasons to suspect that genetic factors are related to the pathophysiology of cervicocephalic dissection. As an example, patients with a family history of arterial dissections involving cervicocephalic arteries, renal arteries or the aorta appear to be at increased risk for recurrent arterial dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. Furthermore, patients with apparently sporadic cervicocephalic artery dissection have a high prevalence of ultrastructural connective tissue abnormalities that are not associated with any defined collagen vascular disease. (See",
"    <a class=\"local\" href=\"#H163601652\">",
"     'Pathology'",
"    </a>",
"    above.) In some families, these connective tissue alterations appear to be transmitted in an autosomal dominant pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/83,84\">",
"     83,84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H447249096\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spontaneous dissection is a common cause of stroke, particularly in young adults, where it accounts for approximately 20 percent of ischemic stroke. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23513?source=see_link&amp;anchor=H11#H11\">",
"     \"Ischemic stroke in children and young adults: Etiology and clinical features\", section on 'Dissection'",
"    </a>",
"    .) A population-based study from Minnesota reported that the average annual incidence rate for spontaneous internal carotid artery dissection was 1.72 per 100,000 individuals, while that for spontaneous vertebral artery dissection was 0.97 per 100,000; the combined annual incidence of spontaneous dissection was 2.6 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/8\">",
"     8",
"    </a>",
"    ]. The true incidence is probably even higher, since many cases of dissection may escape detection because they have minor or no clinical signs [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/50\">",
"     50",
"    </a>",
"    ]. In studies from North America and Europe, the mean age of individuals affected by dissection was 44 to 46 years [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. There is no clear gender or ethnic predilection, although some studies have shown a slight predominance for men or women [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/8-10,50,85,86\">",
"     8-10,50,85,86",
"    </a>",
"    ]. Dissection may be more common in winter, although the cause of seasonal variation remains unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95541757\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence from population- and hospital-based reports suggests that dissection most often results in ischemic stroke or transient ischemic attack, usually associated with local symptoms such as neck pain or headache [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/8-10,88\">",
"     8-10,88",
"    </a>",
"    ]. However, these studies may underestimate the proportion of cases that are asymptomatic or associated with local symptoms only [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H525094949\">",
"    <span class=\"h2\">",
"     Local symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most frequent initial symptom of cervicocephalic dissection is head",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neck pain, found in 60 to 90 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/8,88-91\">",
"     8,88-91",
"    </a>",
"    ]. Although the onset of headache is usually gradual, a sudden and severe onset of pain consistent with a thunderclap headache occurs in up to 20 percent of patients with headache due to dissection (",
"    <a class=\"graphic graphic_table graphicRef81710 \" href=\"UTD.htm?30/1/30747\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/92\">",
"     92",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=see_link\">",
"     \"Thunderclap headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Horner syndrome (",
"    <a class=\"graphic graphic_figure graphicRef80623 \" href=\"UTD.htm?23/54/24424\">",
"     figure 3",
"    </a>",
"    ) occurs in approximately 25 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/8\">",
"     8",
"    </a>",
"    ], and is due most often to distension of sympathetic fibers spanning the external surface of the internal carotid artery. The Horner syndrome seen with internal carotid artery dissection is usually partial, involving ptosis and miosis but not anhidrosis. This occurs because the sympathetic fibers responsible for facial sweating and vasodilation branch off at the superior cervical ganglion from the remainder of the oculosympathetic pathway and travel with the external carotid artery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32262?source=see_link\">",
"     \"Horner's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other manifestations of dissection may include tinnitus [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/93\">",
"     93",
"    </a>",
"    ], an audible bruit, cranial neuropathies (",
"    <a class=\"graphic graphic_figure graphicRef86467 \" href=\"UTD.htm?2/29/2522\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/5,94\">",
"     5,94",
"    </a>",
"    ], or scalp tenderness. Cervical nerve root involvement is a rare complication of vertebral artery dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/95\">",
"     95",
"    </a>",
"    ], while isolated orbital or monocular pain is a rare presentation of carotid artery dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/96,97\">",
"     96,97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95541764\">",
"    <span class=\"h2\">",
"     Ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a population-based report of 48 patients with spontaneous dissection of the internal carotid and vertebral arteries, cerebral ischemia was noted in 67 percent, with transient ischemic attacks and cerebral infarction in 23 and 56 percent respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/8\">",
"     8",
"    </a>",
"    ]. Retinal artery occlusion or ischemic optic neuropathy may also occur [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/9,98,99\">",
"     9,98,99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vertebral dissection may lead to lateral medullary infarction (Wallenberg syndrome), other posterior circulation territory infarction, or spinal cord ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H422537689\">",
"    <span class=\"h2\">",
"     Subarachnoid hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracranial arterial dissection may result in subarachnoid hemorrhage in a minority of cases. In two large hospital-based studies with a combined total of over 1100 patients with cervicocephalic dissection, mainly extracranial, subarachnoid hemorrhage was observed in 1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In a series of 10 patients with intracranial internal carotid artery dissection, 8 had an ischemic stroke, while 1 had an ischemic stroke and an associated subarachnoid hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H701036225\">",
"    <span class=\"h2\">",
"     Internal carotid versus vertebral dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aside from obvious differences in neurologic symptoms and signs related to their different territories, carotid and vertebral dissections may differ in risk factors, other clinical features, and outcome. One of the largest observational studies evaluating these characteristics (the CADISP study) included 982 patients with cervical artery dissection, and excluded those with purely intracranial dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/88\">",
"     88",
"    </a>",
"    ]. The following statistically significant observations were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mean age was slightly higher for patients with internal carotid artery dissection compared with vertebral artery dissection (46 versus 41 years)",
"     </li>",
"     <li>",
"      The proportion of men was higher for internal carotid dissection (60 versus 51 percent)",
"     </li>",
"     <li>",
"      Infection in the previous week was more common with internal carotid dissection (22 versus 15 percent)",
"     </li>",
"     <li>",
"      Minor cervical trauma in the previous month was more frequent with vertebral dissection (37 versus 29 percent)",
"     </li>",
"     <li>",
"      Neck pain was more frequent with vertebral dissection (66 versus 39 percent)",
"     </li>",
"     <li>",
"      Ischemic stroke was more common with vertebral dissection (77 versus 60 percent)",
"     </li>",
"     <li>",
"      Transient monocular blindness occurred only with internal carotid dissection (8 versus 0 percent)",
"     </li>",
"     <li>",
"      The mean National Institutes of Health Stroke Scale score at presentation among those with stroke was higher with internal carotid dissection (8 versus 3)",
"     </li>",
"     <li>",
"      Bilateral dissection was more frequent with vertebral dissection (16 versus 10 percent)",
"     </li>",
"     <li>",
"      Aneurysmal dilatation was more common with internal carotid dissection (14 versus 8 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Of note, there were no significant differences between internal carotid and vertebral dissection for the occurrence of headache (68 and 65 percent), transient ischemic attack not including transient monocular blindness (20 versus 21 percent), arterial occlusion (34 versus 33 percent), or mural hematoma (83 versus 78 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95541778\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;While clinical features may raise suspicion for dissection, the diagnosis is confirmed by neuroimaging findings, particularly the demonstration of a long tapered arterial stenosis, a tapered occlusion, a dissecting aneurysm (pseudoaneurysm), an intimal flap, a double lumen, or an intramural hematoma. (See",
"    <a class=\"local\" href=\"#H95541785\">",
"     'Neuroimaging'",
"    </a>",
"    below.) Headache or neck pain at onset may suggest underlying dissection, especially as a cause of stroke in the young. The acute onset of Horner syndrome in association with neck pain and an ischemic stroke or transient ischemic attack in the territory of the ipsilateral internal carotid artery is suggestive of spontaneous carotid artery dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest lumbar puncture and cerebrospinal fluid analysis to exclude subarachnoid hemorrhage for patients with suspected dissection who have severe or sudden onset headache, and for patients who have intracranial dissection or intracranial extension of extracranial dissection, particularly if treatment with anticoagulation is being considered [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95541785\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vascular imaging is used to confirm an initial diagnosis of cervicocephalic dissection and to guide serial treatment decisions. In most centers, conventional angiography has been supplanted by noninvasive approaches, particularly brain MRI with magnetic resonance angiography (MRA) and cranial CT with computed tomography angiography (CTA) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/101-103\">",
"     101-103",
"    </a>",
"    ]. A systematic review published in 2009 found that the sensitivity and specificity of MR techniques and CTA for the diagnosis of cervicocephalic arterial dissection are relatively similar [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/101\">",
"     101",
"    </a>",
"    ]. We reserve the use of conventional angiography for younger patients when clinical suspicion for dissection remains high despite negative noninvasive imaging.",
"   </p>",
"   <p>",
"    Angiographic findings of dissection include a string sign (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef65212 \" href=\"UTD.htm?12/48/13061\">",
"     image 1",
"    </a>",
"    ), tapered stenosis or occlusion or flame-shaped occlusion (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61851 \" href=\"UTD.htm?25/1/25620\">",
"     image 2",
"    </a>",
"    ), intimal flap (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55635 \" href=\"UTD.htm?7/9/7319\">",
"     image 3",
"    </a>",
"    ), dissecting aneurysm (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef80873 \" href=\"UTD.htm?42/37/43601\">",
"     image 4",
"    </a>",
"    ), distal pouch, and underlying arteriopathy. Multimodal CT or MRI, including CTA or MRA, may illustrate luminal abnormalities, arterial wall expansion, intramural hematoma, and surrounding structures. In a population-based study of 48 consecutive patients with cervical artery dissection, the diagnostic neuroimaging patterns were an elongated tapered stenosis, a tapered occlusion, and a dissecting aneurysm in 48, 35, and 17 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/8\">",
"     8",
"    </a>",
"    ]. In a prospective European study of patients with spontaneous vertebral artery dissection, the most frequent diagnostic neuroimaging finding on MRI was intramural hematoma, which was observed in 91 percent of 157 vertebral artery dissections.",
"   </p>",
"   <p>",
"    Extracranial carotid dissections typically occur 2 cm or more beyond the carotid bifurcation at the level of the skull base. Intracranial carotid dissections are most frequent in the supraclinoid segment [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/7\">",
"     7",
"    </a>",
"    ]. Vertebral artery dissection most often occurs in the cervical transverse processes of C6 to C2 (V2 segment) or the extracranial segment between the transverse process of C2 and the foramen magnum at the base of the skull (V3 segment) [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/100\">",
"     100",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathognomonic crescent sign of intramural hematoma is formed by an eccentric rim of hyperintensity surrounding a hypointense arterial lumen on MRI (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59392 \" href=\"UTD.htm?13/10/13472\">",
"     image 5",
"    </a>",
"    ). This crescent sign has traditionally been described on T1-weighted fat-saturation MRI sequences, but may be apparent on other sequences such as diffusion-weighted imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/104\">",
"     104",
"    </a>",
"    ] or even apparent on CT angiography. The degree of MRI hyperintensity or methemoglobin content of the intramural hematoma varies with age of the lesion. Dissections of the horizontal vertebral artery segment may be difficult to diagnose as the classic crescent may be missing due to orientation of the vessel and the vertebral venous plexus may also appear hyperintense. The orientation of the vertebral artery may also limit delineation of a crescent, as the lumen may be patent yet surrounded by a more irregular \"suboccipital rind\" sign [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/105\">",
"     105",
"    </a>",
"    ]. Assessment of multimodal CT or MRI source images is crucial to define vessel wall abnormalities.",
"   </p>",
"   <p>",
"    Carotid duplex and transcranial Doppler ultrasonography (TCD) may be used to screen for suspected dissection, or to monitor therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/106-109\">",
"     106-109",
"    </a>",
"    ]. However, carotid duplex detects abnormalities in only 68 to 95 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/106,110\">",
"     106,110",
"    </a>",
"    ]. In addition, duplex and transcranial Doppler have a suboptimal yield for identifying arterial dissection near the skull base and vertebral artery dissection within the transverse foramina [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/50,103\">",
"     50,103",
"    </a>",
"    ]. In addition, ultrasound is unreliable for detecting carotid artery dissection in patients with an isolated Horner syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/111\">",
"     111",
"    </a>",
"    ]. Therefore, confirmation with MRA or CTA should be pursued in ultrasound-negative cases when the clinical history is suggestive of dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/112\">",
"     112",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pattern of brain ischemia on diffusion-weighted MRI may be influenced by the patency of the dissected artery, with territorial rather than borderzone infarcts apparent when there is complete occlusion of the vessel [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/113\">",
"     113",
"    </a>",
"    ]. The advent of high-resolution 3 Tesla MRI has made it possible to detail interval recanalization, degree of stenosis, formation of dissecting aneurysms and the appearance of new dissections as part of serial imaging evaluations [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/114\">",
"     114",
"    </a>",
"    ]. Periarterial inflammation associated with dissection may also be visualized with such high-resolution MRI techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/115\">",
"     115",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95541799\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of cervicocephalic dissection is broad, given that the manifestations may include local symptoms (primarily head and neck pain, Horner syndrome, lower cranial nerve palsy), brain ischemia, or subarachnoid hemorrhage, either in isolation or in combination. (See",
"    <a class=\"local\" href=\"#H95541757\">",
"     'Clinical features'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Entities to be considered in the differential diagnosis of head and neck pain include various types of headache, particularly those with unilateral head pain and those accompanied by autonomic symptoms such as ptosis and miosis. The list includes migraine, cluster headache and other trigeminal autonomic cephalalgias (eg, paroxysmal hemicrania and SUNCT syndrome), and Raeder paratrigeminal neuralgia [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/90\">",
"     90",
"    </a>",
"    ]. Migraine should be suspected when there is a characteristic march of transient neurological deficits, although this pattern has been reported as well in rare patients with internal carotid artery dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?10/30/10730/abstract/116\">",
"     116",
"    </a>",
"    ]. Cluster headache typically occurs without focal deficits. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=see_link\">",
"     \"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8600?source=see_link\">",
"     \"Pathophysiology, clinical features, and diagnosis of migraine in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/63/14327?source=see_link\">",
"     \"Cluster headache: Epidemiology, clinical features, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25545?source=see_link\">",
"     \"Paroxysmal hemicrania: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11431?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of craniofacial pain\", section on 'Raeder paratrigeminal syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thunderclap headache &ndash; a severe headache of sudden onset &ndash; occurs in a minority of patients with cervicocephalic dissection. In addition, thunderclap headache is characteristic of the pain associated with the onset of subarachnoid hemorrhage and can be associated with multiple other causes as listed in the table (",
"    <a class=\"graphic graphic_table graphicRef81710 \" href=\"UTD.htm?30/1/30747\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=see_link\">",
"     \"Thunderclap headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis of brain ischemia includes cardiogenic embolism, large artery atherosclerosis, small vessel disease, and a host of less common mechanisms such as a vasculopathy other than spontaneous dissection. Intracranial vertebral artery occlusive disease due to atherosclerosis is a more common cause of lateral medullary ischemia than is vertebral dissection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/37/36439?source=see_link\">",
"     \"Differential diagnosis of transient ischemic attack and stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9208?source=see_link\">",
"     \"Etiology and classification of stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23513?source=see_link\">",
"     \"Ischemic stroke in children and young adults: Etiology and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39273?source=see_link&amp;anchor=H8#H8\">",
"     \"Posterior circulation cerebrovascular syndromes\", section on 'Lateral medullary infarction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis of subarachnoid hemorrhage includes saccular aneurysm rupture, bleeding from a vascular malformation, perimesencephalic nonaneurysmal subarachnoid hemorrhage, and a number of less common causes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/50/38696?source=see_link\">",
"     \"Nonaneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/18/6441?source=see_link\">",
"     \"Perimesencephalic nonaneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Angiographic features of dissection must be distinguished from atherosclerosis, radiation arteriopathy, and congenital hypoplasia of an artery. All of these conditions may produce an angiographic &ldquo;string sign&rdquo; that is commonly seen with dissection. The luminal contour of narrowing caused by dissection may be similar to atherosclerosis, fibromuscular dysplasia, vascular webs, stationary waves, and arteritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95541806\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment and prognosis of cervicocephalic dissection is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/28/21960?source=see_link\">",
"     \"Spontaneous cerebral and cervical artery dissection: Treatment and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95541848\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Separation of the arterial wall layers results in dissection. A false lumen arises in the space where blood seeps into the vessel wall (",
"      <a class=\"graphic graphic_figure graphicRef57866 \" href=\"UTD.htm?17/18/17698\">",
"       figure 1",
"      </a>",
"      ). Hemorrhage may be due to an intimal tear or result from rupture or other pathology in the vasa vasorum. Subintimal dissections cause luminal stenosis or occlusion whereas subadventitial dissections largely result in dissecting aneurysm formation (",
"      <a class=\"graphic graphic_figure graphicRef57174 \" href=\"UTD.htm?24/48/25349\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H163601625\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dissection may result from a combination of intrinsic deficiencies of vessel wall integrity and extrinsic factors, including minor trauma. Numerous proposed risk factors and inciting activities have been associated with dissection. (See",
"      <a class=\"local\" href=\"#H95541729\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Spontaneous dissection of the cervical and cerebral arteries occurs in about 3 cases per 100,000 individuals across all ages, yet accounts for up to one quarter of all stroke cases in the young. (See",
"      <a class=\"local\" href=\"#H447249096\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evidence from population and hospital-based reports suggests that dissection most often results ischemic stroke or transient ischemic attack, usually preceded by local symptoms such as neck pain or headache. However, these studies may underestimate the proportion of cases that are asymptomatic or associated with local symptoms only. Uncommonly, intracranial dissection results in subarachnoid hemorrhage. (See",
"      <a class=\"local\" href=\"#H95541757\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of cervicocephalic dissection is confirmed by neuroimaging findings, particularly the demonstration of a long tapered arterial stenosis, a tapered occlusion, a dissecting aneurysm (pseudoaneurysm), an intimal flap, a double lumen, or an intramural hematoma. Various neuroimaging modalities may be used to confirm a diagnosis of dissection. In most centers, conventional angiography has been supplanted by brain MRI with magnetic resonance angiography or by cranial CT with computed tomography angiography. (See",
"      <a class=\"local\" href=\"#H95541778\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment and prognosis of cervicocephalic dissection is reviewed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/28/21960?source=see_link\">",
"       \"Spontaneous cerebral and cervical artery dissection: Treatment and prognosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/1\">",
"      Pannone A, Lucchetti G, Stazi G, et al. Internal carotid artery dissection in a patient with Beh&ccedil;et's syndrome. Ann Vasc Surg 1998; 12:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/2\">",
"      V&ouml;lker W, Dittrich R, Grewe S, et al. The outer arterial wall layers are primarily affected in spontaneous cervical artery dissection. Neurology 2011; 76:1463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/3\">",
"      Lucas C, Moulin T, Deplanque D, et al. Stroke patterns of internal carotid artery dissection in 40 patients. Stroke 1998; 29:2646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/4\">",
"      Morel A, Naggara O, Touz&eacute; E, et al. Mechanism of ischemic infarct in spontaneous cervical artery dissection. Stroke 2012; 43:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/5\">",
"      Mattioni A, Paciaroni M, Sarchielli P, et al. Multiple cranial nerve palsies in a patient with internal carotid artery dissection. Eur Neurol 2007; 58:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/6\">",
"      Kim BM, Kim SH, Kim DI, et al. Outcomes and prognostic factors of intracranial unruptured vertebrobasilar artery dissection. Neurology 2011; 76:1735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/7\">",
"      Chaves C, Estol C, Esnaola MM, et al. Spontaneous intracranial internal carotid artery dissection: report of 10 patients. Arch Neurol 2002; 59:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/8\">",
"      Lee VH, Brown RD Jr, Mandrekar JN, Mokri B. Incidence and outcome of cervical artery dissection: a population-based study. Neurology 2006; 67:1809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/9\">",
"      Arnold M, Kappeler L, Georgiadis D, et al. Gender differences in spontaneous cervical artery dissection. Neurology 2006; 67:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/10\">",
"      Touz&eacute; E, Gauvrit JY, Moulin T, et al. Risk of stroke and recurrent dissection after a cervical artery dissection: a multicenter study. Neurology 2003; 61:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/11\">",
"      Hassan AE, Zacharatos H, Mohammad YM, et al. Comparison of single versus multiple spontaneous extra- and/or intracranial arterial dissection. J Stroke Cerebrovasc Dis 2013; 22:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/12\">",
"      Arnold M, De Marchis GM, Stapf C, et al. Triple and quadruple spontaneous cervical artery dissection: presenting characteristics and long-term outcome. J Neurol Neurosurg Psychiatry 2009; 80:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/13\">",
"      Besselmann M, Vennemann B, Lowens S, et al. Internal carotid artery dissection. Neurology 2000; 54:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/14\">",
"      Ulbricht D, Diederich NJ, Hermanns-L&ecirc; T, et al. Cervical artery dissection: An atypical presentation with Ehlers-Danlos-like collagen pathology? Neurology 2004; 63:1708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/15\">",
"      Brandt T, Morcher M, Hausser I. Association of cervical artery dissection with connective tissue abnormalities in skin and arteries. Front Neurol Neurosci 2005; 20:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/16\">",
"      Brandt T, Orberk E, Weber R, et al. Pathogenesis of cervical artery dissections: association with connective tissue abnormalities. Neurology 2001; 57:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/17\">",
"      Karnik R, Rothmund T, Bonner G, et al. Inline skating as a possible cause of consecutive bilateral vertebral artery dissection. Acta Neurol Scand 2000; 101:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/18\">",
"      Abe A, Nishiyama Y, Kamiyama H, et al. Symptomatic middle cerebral artery dissection in a young tennis player. J Nippon Med Sch 2009; 76:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/19\">",
"      DeBehnke DJ, Brady W. Vertebral artery dissection due to minor neck trauma. J Emerg Med 1994; 12:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/20\">",
"      De Giorgio F, Vetrugno G, De Mercurio D, et al. 1. Dissection of the vertebral artery during a basketball game: a case report. Med Sci Law 2004; 44:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/21\">",
"      Slankamenac P, Jesic A, Avramov P, et al. Multiple cervical artery dissection in a volleyball player. Arch Neurol 2010; 67:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/22\">",
"      Furtner M, Werner P, Felber S, Schmidauer C. Bilateral carotid artery dissection caused by springboard diving. Clin J Sport Med 2006; 16:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/23\">",
"      Bartsch T, Palaschewski M, Thilo B, et al. Internal carotid artery dissection and stroke after SCUBA diving: a case report and review of the literature. J Neurol 2009; 256:1916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/24\">",
"      Skurnik YD, Sthoeger Z. Carotid artery dissection after scuba diving. Isr Med Assoc J 2005; 7:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/25\">",
"      Gibbs JW 3rd, Piantadosi CA, Massey EW. Internal carotid artery dissection in stroke from SCUBA diving: a case report. Undersea Hyperb Med 2002; 29:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/26\">",
"      Konno K, Kurita H, Ito N, et al. Extracranial vertebral artery dissection caused by scuba diving. J Neurol 2001; 248:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/27\">",
"      Mayer SA, Rubin BS, Starman BJ, Byers PH. Spontaneous multivessel cervical artery dissection in a patient with a substitution of alanine for glycine (G13A) in the alpha 1 (I) chain of type I collagen. Neurology 1996; 47:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/28\">",
"      Nelson EE. Internal carotid artery dissection associated with scuba diving. Ann Emerg Med 1995; 25:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/29\">",
"      Faivre A, Abdelfettah Z, Rodriguez S, Nicoli F. Neurological picture. Bilateral internal carotid artery dissection due to elongated styloid processes and shaking dancing. J Neurol Neurosurg Psychiatry 2009; 80:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/30\">",
"      Prabhakar S, Bhatia R, Khandelwal N, et al. Vertebral artery dissection due to indirect neck trauma : an underrecognised entity. Neurol India 2001; 49:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/31\">",
"      Caso V, Paciaroni M, Bogousslavsky J. Environmental factors and cervical artery dissection. Front Neurol Neurosci 2005; 20:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/32\">",
"      Wechsler B, Kim H, Hunter J. Trampolines, children, and strokes. Am J Phys Med Rehabil 2001; 80:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/33\">",
"      Burneo JG, Shatz R, Papamitsakis NI, Mitsias PD. Neuroimages: amusement park stroke. Neurology 2000; 55:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/34\">",
"      Sheikh SI, Singhal AB. Extension of \"roller coaster dissection\" after tissue plasminogen activator. AJNR Am J Neuroradiol 2010; 31:E4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/35\">",
"      Schneck M, Simionescu M, Bijari A. Bilateral vertebral artery dissection possibly precipitated in delayed fashion as a result of roller coaster rides. J Stroke Cerebrovasc Dis 2008; 17:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/36\">",
"      Blacker DJ, Wijdicks EF. A ripping roller coaster ride. Neurology 2003; 61:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/37\">",
"      Lascelles K, Hewes D, Ganesan V. An unexpected consequence of a roller coaster ride. J Neurol Neurosurg Psychiatry 2001; 71:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/38\">",
"      Biousse V, Chabriat H, Amarenco P, Bousser MG. Roller-coaster-induced vertebral artery dissection. Lancet 1995; 346:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/39\">",
"      Faivre A, Chapon F, Combaz X, Nicoli F. Internal carotid artery dissection occurring during intensive practice with Wii video sports games. Neurology 2009; 73:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/40\">",
"      Dharmasaroja P, Dharmasaroja P. Sports-related internal carotid artery dissection: pathogenesis and therapeutic point of view. Neurologist 2008; 14:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/41\">",
"      Stamboulis E, Raptis G, Andrikopoulou A, et al. Spontaneous internal carotid artery dissection: an uncommon cause of recurrent postpartum headache. J Neuroimaging 2011; 21:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/42\">",
"      Delasobera BE, Osborn SR, Davis JE. Thunderclap headache with orgasm: a case of basilar artery dissection associated with sexual intercourse. J Emerg Med 2012; 43:e43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/43\">",
"      Paciaroni M, Bogousslavsky J. Cerebrovascular complications of neck manipulation. Eur Neurol 2009; 61:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/44\">",
"      Reuter U, H&auml;mling M, Kavuk I, et al. Vertebral artery dissections after chiropractic neck manipulation in Germany over three years. J Neurol 2006; 253:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/45\">",
"      Leon-Sanchez A, Cuetter A, Ferrer G. Cervical spine manipulation: an alternative medical procedure with potentially fatal complications. South Med J 2007; 100:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/46\">",
"      Smith WS, Johnston SC, Skalabrin EJ, et al. Spinal manipulative therapy is an independent risk factor for vertebral artery dissection. Neurology 2003; 60:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/47\">",
"      Ernst E. Adverse effects of spinal manipulation: a systematic review. J R Soc Med 2007; 100:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/48\">",
"      Gouveia LO, Castanho P, Ferreira JJ. Safety of chiropractic interventions: a systematic review. Spine (Phila Pa 1976) 2009; 34:E405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/49\">",
"      Gdynia HJ, K&uuml;hnlein P, Ludolph AC, Huber R. Connective tissue disorders in dissections of the carotid or vertebral arteries. J Clin Neurosci 2008; 15:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/50\">",
"      Debette S, Leys D. Cervical-artery dissections: predisposing factors, diagnosis, and outcome. Lancet Neurol 2009; 8:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/51\">",
"      de Bray JM, Marc G, Pautot V, et al. Fibromuscular dysplasia may herald symptomatic recurrence of cervical artery dissection. Cerebrovasc Dis 2007; 23:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/52\">",
"      Olin JW, Froehlich J, Gu X, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation 2012; 125:3182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/53\">",
"      Rouvi&egrave;re S, Michelini R, Sarda P, Pag&egrave;s M. Spontaneous carotid artery dissection in two siblings with osteogenesis imperfecta. Cerebrovasc Dis 2004; 17:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/54\">",
"      Thal DR, Schober R, Schlote W. Carotid artery dissection in a young adult: cystic medial necrosis associated with an increased elastase content. Clin Neuropathol 1997; 16:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/55\">",
"      Heged&uuml;s K. Reticular fiber deficiency in the intracranial arteries of patients with dissecting aneurysm and review of the possible pathogenesis of previously reported cases. Eur Arch Psychiatry Neurol Sci 1985; 235:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/56\">",
"      Weiss N, Demeret S, Sonneville R, et al. Bilateral internal carotid artery dissection in cystathionine beta-synthase deficiency. Eur Neurol 2006; 55:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/57\">",
"      Larranaga J, Rutecki GW, Whittier FC. Spontaneous vertebral artery dissection as a complication of autosomal dominant polycystic kidney disease. Am J Kidney Dis 1995; 25:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/58\">",
"      Vila N, Mill&aacute;n M, Ferrer X, et al. Levels of alpha1-antitrypsin in plasma and risk of spontaneous cervical artery dissections: a case-control study. Stroke 2003; 34:E168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/59\">",
"      Fantaneanu T, Veinot JP, Torres C, et al. Cervical arterial dissections due to segmental mediolytic arteriopathy. Neurology 2011; 77:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/60\">",
"      Debette S, Markus HS. The genetics of cervical artery dissection: a systematic review. Stroke 2009; 40:e459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/61\">",
"      Grond-Ginsbach C, Debette S. The association of connective tissue disorders with cervical artery dissections. Curr Mol Med 2009; 9:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/62\">",
"      Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001; 344:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/63\">",
"      Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000; 342:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/64\">",
"      Schievink WI, Bj&ouml;rnsson J, Piepgras DG. Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfan's syndrome and bilateral carotid artery dissections. Stroke 1994; 25:2492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/65\">",
"      Harrer JU, Sasse A, Kl&ouml;tzsch C. Intimal flap in a common carotid artery in a patient with Marfan's syndrome. Ultraschall Med 2006; 27:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/66\">",
"      Wityk RJ, Zanferrari C, Oppenheimer S. Neurovascular complications of marfan syndrome: a retrospective, hospital-based study. Stroke 2002; 33:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/67\">",
"      Faivre L, Collod-Beroud G, Loeys BL, et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 2007; 81:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/68\">",
"      Pezzini A, Caso V, Zanferrari C, et al. Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study. J Neurol Neurosurg Psychiatry 2006; 77:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/69\">",
"      Metso TM, Metso AJ, Salonen O, et al. Adult cervicocerebral artery dissection: a single-center study of 301 Finnish patients. Eur J Neurol 2009; 16:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/70\">",
"      Guillon B, Berthet K, Benslamia L, et al. Infection and the risk of spontaneous cervical artery dissection: a case-control study. Stroke 2003; 34:e79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/71\">",
"      Benninger DH, Herrmann FR, Georgiadis D, et al. Increased prevalence of hyperhomocysteinemia in cervical artery dissection causing stroke: a case-control study. Cerebrovasc Dis 2009; 27:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/72\">",
"      Fel&iacute;cio AC, Silva GS, dos Santos WA, et al. Spontaneous artery dissection in a patient with Human Immunodeficiency Virus (HIV) infection. Arq Neuropsiquiatr 2006; 64:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/73\">",
"      Barbour PJ, Castaldo JE, Rae-Grant AD, et al. Internal carotid artery redundancy is significantly associated with dissection. Stroke 1994; 25:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/74\">",
"      Rubinstein SM, Peerdeman SM, van Tulder MW, et al. A systematic review of the risk factors for cervical artery dissection. Stroke 2005; 36:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/75\">",
"      Arnold M, Pannier B, Chabriat H, et al. Vascular risk factors and morphometric data in cervical artery dissection: a case-control study. J Neurol Neurosurg Psychiatry 2009; 80:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/76\">",
"      Debette S, Metso T, Pezzini A, et al. Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults. Circulation 2011; 123:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/77\">",
"      Raser JM, Mullen MT, Kasner SE, et al. Cervical carotid artery dissection is associated with styloid process length. Neurology 2011; 77:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/78\">",
"      Metso TM, Tatlisumak T, Debette S, et al. Migraine in cervical artery dissection and ischemic stroke patients. Neurology 2012; 78:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/79\">",
"      Rist PM, Diener HC, Kurth T, Sch&uuml;rks M. Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia 2011; 31:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/80\">",
"      Schievink WI, Mokri B, Piepgras DG. Angiographic frequency of saccular intracranial aneurysms in patients with spontaneous cervical artery dissection. J Neurosurg 1992; 76:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/81\">",
"      Martin JJ, Hausser I, Lyrer P, et al. Familial cervical artery dissections: clinical, morphologic, and genetic studies. Stroke 2006; 37:2924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/82\">",
"      Schievink WI, Mokri B, Piepgras DG, Kuiper JD. Recurrent spontaneous arterial dissections: risk in familial versus nonfamilial disease. Stroke 1996; 27:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/83\">",
"      Grond-Ginsbach C, Klima B, Weber R, et al. Exclusion mapping of the genetic predisposition for cervical artery dissections by linkage analysis. Ann Neurol 2002; 52:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/84\">",
"      Wiest T, Hyrenbach S, Bambul P, et al. Genetic analysis of familial connective tissue alterations associated with cervical artery dissections suggests locus heterogeneity. Stroke 2006; 37:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/85\">",
"      Beletsky V, Nadareishvili Z, Lynch J, et al. Cervical arterial dissection: time for a therapeutic trial? Stroke 2003; 34:2856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/86\">",
"      Schievink WI, Mokri B, O'Fallon WM. Recurrent spontaneous cervical-artery dissection. N Engl J Med 1994; 330:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/87\">",
"      Paciaroni M, Georgiadis D, Arnold M, et al. Seasonal variability in spontaneous cervical artery dissection. J Neurol Neurosurg Psychiatry 2006; 77:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/88\">",
"      Debette S, Grond-Ginsbach C, Bodenant M, et al. Differential features of carotid and vertebral artery dissections: the CADISP study. Neurology 2011; 77:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/89\">",
"      Mokri B, Sundt TM Jr, Houser OW, Piepgras DG. Spontaneous dissection of the cervical internal carotid artery. Ann Neurol 1986; 19:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/90\">",
"      Manabe H, Yonezawa K, Kato T, et al. Incidence of intracranial arterial dissection in non-emergency outpatients complaining of headache: preliminary investigation with MRI/MRA examinations. Acta Neurochir Suppl 2010; 107:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/91\">",
"      Silbert PL, Mokri B, Schievink WI. Headache and neck pain in spontaneous internal carotid and vertebral artery dissections. Neurology 1995; 45:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/92\">",
"      Mitsias P, Ramadan NM. Headache in ischemic cerebrovascular disease. Part I: Clinical features. Cephalalgia 1992; 12:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/93\">",
"      Pelkonen O, Tikkakoski T, Luotonen J, Sotaniemi K. Pulsatile tinnitus as a symptom of cervicocephalic arterial dissection. J Laryngol Otol 2004; 118:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/94\">",
"      Mokri B, Silbert PL, Schievink WI, Piepgras DG. Cranial nerve palsy in spontaneous dissection of the extracranial internal carotid artery. Neurology 1996; 46:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/95\">",
"      Crum B, Mokri B, Fulgham J. Spinal manifestations of vertebral artery dissection. Neurology 2000; 55:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/96\">",
"      Guillon B, Biousse V, Massiou H, Bousser MG. Orbital pain as an isolated sign of internal carotid artery dissection. A diagnostic pitfall. Cephalalgia 1998; 18:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/97\">",
"      Richoz O, Scott Schutz J, M&eacute;gevand P. Pearls &amp; Oy-sters: unusual manifestations of bilateral carotid artery dissection: deep monocular pains. Neurology 2012; 78:e16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/98\">",
"      Biousse V, Touboul PJ, D'Anglejan-Chatillon J, et al. Ophthalmologic manifestations of internal carotid artery dissection. Am J Ophthalmol 1998; 126:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/99\">",
"      Biousse V, Schaison M, Touboul PJ, et al. Ischemic optic neuropathy associated with internal carotid artery dissection. Arch Neurol 1998; 55:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/100\">",
"      Arnold M, Bousser MG, Fahrni G, et al. Vertebral artery dissection: presenting findings and predictors of outcome. Stroke 2006; 37:2499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/101\">",
"      Provenzale JM, Sarikaya B. Comparison of test performance characteristics of MRI, MR angiography, and CT angiography in the diagnosis of carotid and vertebral artery dissection: a review of the medical literature. AJR Am J Roentgenol 2009; 193:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/102\">",
"      Vertinsky AT, Schwartz NE, Fischbein NJ, et al. Comparison of multidetector CT angiography and MR imaging of cervical artery dissection. AJNR Am J Neuroradiol 2008; 29:1753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/103\">",
"      Provenzale JM. MRI and MRA for evaluation of dissection of craniocerebral arteries: lessons from the medical literature. Emerg Radiol 2009; 16:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/104\">",
"      Choi KD, Jo JW, Park KP, et al. Diffusion-weighted imaging of intramural hematoma in vertebral artery dissection. J Neurol Sci 2007; 253:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/105\">",
"      Lum C, Chakraborty S, Schlossmacher M, et al. Vertebral artery dissection with a normal-appearing lumen at multisection CT angiography: the importance of identifying wall hematoma. AJNR Am J Neuroradiol 2009; 30:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/106\">",
"      Benninger DH, Baumgartner RW. Ultrasound diagnosis of cervical artery dissection. Front Neurol Neurosci 2006; 21:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/107\">",
"      Imray CH, Pattinson KT. Potential role for TCD-directed antiplatelet agents in symptomatic carotid artery dissection. Stroke 2006; 37:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/108\">",
"      Sengelhoff C, Nebelsieck J, Nassenstein I, et al. Neurosonographical follow-up in patients with spontaneous cervical artery dissection. Neurol Res 2008; 30:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/109\">",
"      Wessels T, Mosso M, Krings T, et al. Extracranial and intracranial vertebral artery dissection: long-term clinical and duplex sonographic follow-up. J Clin Ultrasound 2008; 36:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/110\">",
"      Nebelsieck J, Sengelhoff C, Nassenstein I, et al. Sensitivity of neurovascular ultrasound for the detection of spontaneous cervical artery dissection. J Clin Neurosci 2009; 16:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/111\">",
"      Arnold M, Baumgartner RW, Stapf C, et al. Ultrasound diagnosis of spontaneous carotid dissection with isolated Horner syndrome. Stroke 2008; 39:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/112\">",
"      Dittrich R, Dziewas R, Ritter MA, et al. Negative ultrasound findings in patients with cervical artery dissection. Negative ultrasound in CAD. J Neurol 2006; 253:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/113\">",
"      Bonati LH, Wetzel SG, Gandjour J, et al. Diffusion-weighted imaging in stroke attributable to internal carotid artery dissection: the significance of vessel patency. Stroke 2008; 39:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/114\">",
"      Bachmann R, Nassenstein I, Kooijman H, et al. High-resolution magnetic resonance imaging (MRI) at 3.0 Tesla in the short-term follow-up of patients with proven cervical artery dissection. Invest Radiol 2007; 42:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/115\">",
"      Naggara O, Touz&eacute; E, Marsico R, et al. High-resolution MR imaging of periarterial edema associated with biological inflammation in spontaneous carotid dissection. Eur Radiol 2009; 19:2255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?10/30/10730/abstract/116\">",
"      Silverman IE, Wityk RJ. Transient migraine-like symptoms with internal carotid artery dissection. Clin Neurol Neurosurg 1998; 100:116.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14082 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-3399DFF423-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10730=[""].join("\n");
var outline_f10_30_10730=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H95541848\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H95541708\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H163601625\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H163601652\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H95541729\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H163601532\">",
"      Minor trauma and other triggers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H163601524\">",
"      Predisposing conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H80087852\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H447249096\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H95541757\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H525094949\">",
"      Local symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H95541764\">",
"      Ischemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H422537689\">",
"      Subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H701036225\">",
"      Internal carotid versus vertebral dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H95541778\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H95541785\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H95541799\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H95541806\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H95541848\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/14082\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/14082|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/48/13061\" title=\"diagnostic image 1\">",
"      String sign on MR angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/1/25620\" title=\"diagnostic image 2\">",
"      Flame-shaped occlusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/9/7319\" title=\"diagnostic image 3\">",
"      Intracranial dissection with intimal flap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/37/43601\" title=\"diagnostic image 4\">",
"      Extracranial aneurysm of the internal carotid artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/10/13472\" title=\"diagnostic image 5\">",
"      MRI of ICA dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/14082|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/18/17698\" title=\"figure 1\">",
"      Arterial dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/48/25349\" title=\"figure 2\">",
"      Mechanism of dissecting aneurysm formation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/54/24424\" title=\"figure 3\">",
"      Horner syndrome due to internal carotid artery dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/29/2522\" title=\"figure 4\">",
"      Hypoglossal palsy ICA dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/14082|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/37/5720\" title=\"picture 1\">",
"      Pathology of internal carotid artery dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/14082|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/1/30747\" title=\"table 1\">",
"      Etiologies of thunderclap headache",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/63/14327?source=related_link\">",
"      Cluster headache: Epidemiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/37/36439?source=related_link\">",
"      Differential diagnosis of transient ischemic attack and stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9208?source=related_link\">",
"      Etiology and classification of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38522?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32262?source=related_link\">",
"      Horner's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/61/23513?source=related_link\">",
"      Ischemic stroke in children and young adults: Etiology and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/50/38696?source=related_link\">",
"      Nonaneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11431?source=related_link\">",
"      Overview of craniofacial pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/60/25545?source=related_link\">",
"      Paroxysmal hemicrania: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8600?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of migraine in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/4/26698?source=related_link\">",
"      Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/18/6441?source=related_link\">",
"      Perimesencephalic nonaneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39273?source=related_link\">",
"      Posterior circulation cerebrovascular syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/28/21960?source=related_link\">",
"      Spontaneous cerebral and cervical artery dissection: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=related_link\">",
"      Thunderclap headache",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_30_10731="Card inelig adjuv trastuz";
var content_f10_30_10731=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F74571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F74571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cardiac ineligibility criteria in the NSABP B-31 and NCCTG N9831 adjuvant trastuzumab trials",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Angina pectoris requiring antianginal medication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arrhythmia requiring medication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe conduction abnormality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clinically significant valvular heart disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiomegaly on chest radiography",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Left ventricular hypertrophy on echocardiogram (NSABP B-31 only)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Poorly controlled hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clinically significant pericardial effusion (NCCTG trial N9831 only)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of myocardial infarction, heart failure, or cardiomyopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LVEF below the lower limit of normal",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10731=[""].join("\n");
var outline_f10_30_10731=null;
var title_f10_30_10732="Contraind main Rx prost CA";
var content_f10_30_10732=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Relative contraindications to the main treatment options for early prostate cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        External beam radiation therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Previous pelvic irradiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Active inflammatory disease of the rectum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Very low bladder capacity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic moderate or severe diarrhea from any cause",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Brachytherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Previous pelvic irradiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prior TURP",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Large-volume gland",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marked voiding symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Large or high-grade tumor burdens*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic moderate or severe diarrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Active inflammatory disease of the rectum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Radical prostatectomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Higher medical operative risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neurogenic bladder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Morbid fear of surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Active surveillance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patients with high prostate cancer anxiety",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High-grade tumors (&gt; Gleason 6); not stage T1c",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prolonged expected survival",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    * Brachytherapy may be indicated in combination with external beam RT.",
"    <div class=\"footnotes\">",
"     TURP: transurethral resection of the prostate.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Vogelzang NJ, Scardino PT, Shipley WU, et al. Comprehensive textbook of genitourinary oncology, 3rd Edition. Lippincott Williams &amp; Wilkins 2005. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10732=[""].join("\n");
var outline_f10_30_10732=null;
var title_f10_30_10733="2002 AJCC staging of STS";
var content_f10_30_10733=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F69154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F69154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    AJCC staging system for soft tissue sarcoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"5\">",
"       Primary tumor (T)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       T1",
"      </td>",
"      <td class=\"sublist_other_start\" colspan=\"4\">",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       T1a",
"      </td>",
"      <td class=\"sublist_other\" colspan=\"4\">",
"       Superficial tumor*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       T1b",
"      </td>",
"      <td class=\"sublist_other\" colspan=\"4\">",
"       Deep tumor*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       T2",
"      </td>",
"      <td class=\"sublist_other_start\" colspan=\"4\">",
"       Tumor greater than 5 cm in greatest dimension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       T2a",
"      </td>",
"      <td class=\"sublist_other\" colspan=\"4\">",
"       Superficial tumor",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       T2b",
"      </td>",
"      <td class=\"sublist_other\" colspan=\"4\">",
"       Deep tumor",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"5\">",
"       Regional lymph node (N)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N0",
"      </td>",
"      <td colspan=\"4\">",
"       No histologically verified metastasis to regional lymph nodes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N1",
"      </td>",
"      <td colspan=\"4\">",
"       Histologically verified regional lymph node metastasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"5\">",
"       Distant metastasis (M)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M0",
"      </td>",
"      <td colspan=\"4\">",
"       No distant metastasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M1",
"      </td>",
"      <td colspan=\"4\">",
"       Distant metastasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"5\">",
"       Histologic grade of malignancy (G)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       G1",
"      </td>",
"      <td colspan=\"4\">",
"       Low, well differentiated",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       G2",
"      </td>",
"      <td colspan=\"4\">",
"       Intermediate, moderately well differentiated",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       G3",
"      </td>",
"      <td colspan=\"4\">",
"       High, poorly differentiated",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       G4",
"      </td>",
"      <td colspan=\"4\">",
"       Poorly differentiated or undifferentiated (4-tier systems only)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"5\">",
"       Stage grouping",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Stage I",
"      </td>",
"      <td>",
"       T1a, b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"      <td>",
"       G1-2 (G1 with a 3-tier system)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T2a, b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"      <td>",
"       G1-2 (G1 with a 3-tier system)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Stage II",
"      </td>",
"      <td>",
"       T1a, 1b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"      <td>",
"       G3-4 (G2-3 with a 3-tier system)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T2a",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"      <td>",
"       G3-4 (G2-3 with a 3-tier system)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage III",
"      </td>",
"      <td>",
"       T2b",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"      <td>",
"       G3-4 (G2-3 with a 3-tier system)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Stage IV",
"      </td>",
"      <td>",
"       Any T",
"      </td>",
"      <td>",
"       N1",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"      <td>",
"       Any G",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Any T",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M1",
"      </td>",
"      <td>",
"       Any G",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Superficial tumor is located exclusively above the superficial fascia without invasion of the fascia; deep tumor is located either exclusively beneath the superficial fascia, superficial to the fascia with invasion of or through the fascia, or both superficial yet beneath the fascia. Retroperitoneal, mediastinal, and pelvic sarcomas are classified as deep tumors.",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Sixth Edition (2002) published by Springer-Verlag New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10733=[""].join("\n");
var outline_f10_30_10733=null;
var title_f10_30_10734="Ventilatory responses in HF";
var content_f10_30_10734=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Ventilatory responses during exercise in HF",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 306px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ventilatory responses in a patient with heart failure who underwent exercise testing using a bicyle protocol with a 10 watt/min ramp. The carbon dioxide output (VCO2) paralleled the oxygen uptake (VO2) until minute seven when it increased more rapidly due to the anaerobic component.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10734=[""].join("\n");
var outline_f10_30_10734=null;
var title_f10_30_10735="Short axis LV mitral valve";
var content_f10_30_10735=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F68826&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F68826&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Short axis plane echocardiogram of left ventricle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 267px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The short axis image of the left ventricle (LV), at the level of the mitral valve, shows the tips of the mitral leaflets.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_30_10735=[""].join("\n");
var outline_f10_30_10735=null;
